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Abstract  
Tropane alkaloids (TAs) are toxins found in a wide variety of plant species growing in 
mild climates. The most well-known are Datura, Atropa and Hyoscyamus sp., belonging 
to the Solanaceae family. The TAs family comprises more than 200 compounds, of which 
atropine and scopolamine are the most active producing anticholinergic symptoms (e.g. 
blurred vision, dry mouth, muscle spasms, tachycardia and death) if ingested in toxic 
quantities. The presence of botanical impurities (e.g. seeds, leaves and roots) has been 
reported in a variety of tea and herbal blends, stressing the need to control the quality 
of these products in the EU market. 
The European Union Reference Laboratory (EURL) for Mycotoxins organised a proficiency 
test (PT) on the determination of TAs (atropine and scopolamine) in tea and herbal 
infusions upon request from DG SANTE. The measurand levels were targeted to provide 
insight on the measurement capabilities of EU Member States' laboratories at 
concentrations close to the recommended limit of quantification (LOQ) established by the 
Commission Recommendation 2015/976 (preferably below 5 µg/kg and not higher 10 
µg/kg). Additionally, the ratio of atropine to scopolamine was kept as native in the plant 
materials in some samples. 
Three matrices appropriately processed were provided to the participants: black tea, 
peppermint leaves and fennel seeds. The concentrations of atropine varied from 8.3 to 
42.2 µg/kg while those of scopolamine ranged from 1.5 to 20.8 µg/kg. The participants 
were asked to determine atropine and scopolamine in 6 contaminated samples (2 per 
matrix) and 3 blank materials spiked by them with a TAs solution of unknown 
concentration. This setup was also aimed to allow a preliminary assessment of the 
robustness of the EURL-developed method. 
Thirty-three laboratories from 11 Member States joined the PT, with a very significant 
participation from Germany. The performance of the laboratories was assessed using z-
scores with regard to the assigned values obtained by exact matching double isotope 
dilution mass spectrometry (EMD-IDMS), in line with the ISO 13528:2015. In all cases, 
the consensus values derived from the participants' data were within the range of the 
assigned values, considering the respective confidence intervals. On average, eighty-
seven percent of the z-scores for atropine and 84 % for scopolamine fell in the 
acceptable range (|z| ≤ 2). The success rate varied from 83 to 94 % for atropine and 
from 67 to 94 % for scopolamine, across the distributed matrices and concentration 
levels. The robust standard deviations of the reported results for both TAs were in good 
agreement with the target standard deviation (22 %). 
The results of this PT indicate that EU Member States’ laboratories can determine 
atropine and scopolamine reliably in tea and herbal infusions at levels relevant to the 
current legislation (Commission Recommendation 2015/976). 
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1. Introduction  
Plant toxins have been recognised as one of the most widespread and potent groups of 
toxicants. Tropane alkaloids (TAs) occur mainly in Datura, Atropa and Hyoscyamus sp., 
belonging to the Solanaceae family, besides a variety of other families such as 
Erythroxylaceae, Brassicaceae, Rhizophoraceae, Proteaceae, Euphorbiaceae, 
Convolvulaceae and Cruciferae [1]. Datura stramonium, also known as Jimson weed or 
thorn apple, is widely distributed in temperate and tropical zones of the world. Seeds of 
this plant have been found as impurities in important agricultural crops such as linseed, 
soybean, millet, sunflower and buckwheat and products thereof. Other well-known TA-
containing plants are the deadly nightshade (Atropa belladonna), henbane (Hyoscyamus 
niger) and mandrake (Mandragora officinarum). The consumption of small quantities of 
parts of these plants has caused severe intoxication, including deaths in young children 
[2]. As a result of the anticholinergic activity of the TAs, the following intoxication 
symptoms may be observed: blurred vision, pupil dilation, dry mouth, vomiting, clouded 
consciousness, muscle spasms, low body temperature, hallucinations, tachycardia, and 
ultimately death [1,2]. 
 
Among the over 200 TAs known, the most studied and biologically active are (-)-
hyoscyamine and (-)-scopolamine enantiomers. Due to analytical limitations, it is not 
always possible to distinguish between the enantiomers of hyoscyamine; therefore the 
racemate (atropine) is usually determined [1-3]. Their structures can be found below. 
                                    
      Scopolamine      Atropine 
 
Over the past decades, several TA intoxications from the consumption of contaminated 
herbal teas; e.g. burdock (Arctium) root tea, nettle (Urtica) tea, comfrey (Symphytum) 
tea and Paraguay (Ilex paraguariensis)) tea, were reported [3]. The most often reported 
route of ingestion by humans is through tea (contaminated or mislabelled), although 
ingesting seeds or other plant parts and smoking dried leaves are also common. In 2013 
in the Netherlands, four persons were hospitalized after developing typical signs of 
anticholinergic poisoning within 2 hours after drinking tea prepared from marshmallow 
(Althaea officinalis) root that was contaminated with A. belladonna root. In a survey 
carried out in the Israeli market, out of 8 different herbal teas investigated, atropine and 
scopolamine occurred in 80 % of the peppermint samples with mean values of 171 
µg/kg (range: 20–208 µg/kg) and 81 µg/kg (range: 14–171 µg/kg), respectively. 
Although the concentrations per tea bag were below the recommended acute reference 
dose, frequent consumption of highly contaminated peppermint teas for long periods of 
time might expose humans to hazardous adverse effects [3].  
 
In 2015, the European Commission published a Recommendation to the Member States 
(2015/976) to monitor the presence of tropane alkaloids in food commodities, among 
them: food supplements, teas and herbal infusions [4]. 
A PT was organised by the EURL-Mycotoxins to underpin and assess the measurement 
capability of Member States' laboratories concerning the determination of atropine and 
scopolamine in tea and herbal infusions. Laboratories that didn't have a method already 
implemented for this determination were offered the possibility to request a suitable 
method description. The concentrations of atropine and scopolamine were planned to 
resemble a natural contamination, in part of the samples. 
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2. Scope  
As stated in Article 32 of Regulation (EC) No 882/2004 [5], one of the core duties of the 
EURL is to organise PTs for the benefit of the National Reference Laboratories (NRLs). 
Given the Recommendation 2015/976 [4] from the European Commission and the 
envisaged future legislation setting maximum limits, the EURL-Mycotoxins organised on 
the request of DG SANTE a proficiency test on the determination of tropane alkaloids 
(atropine and scopolamine) in tea and herbal infusions. The target concentration was set 
at the LOQ requirement established in the above mentioned Recommendation (10 
µg/kg) and the levels covered the range from 1.5 to 42 µg/kg, respecting the tropane 
alkaloids' natural proportion. 
This proficiency test was addressed to the EU Member States' competent laboratories 
(designated by the competent national authority) and expert laboratories. Participation 
was free of charge and not mandatory. Forty-two laboratories from 13 Member States 
registered for the PT. 
 
The EURL for Mycotoxins performed the planning, execution and assessment of the 
measurement results based on the requirements laid down in the legislation and 
followed the administrative and logistic procedures of the ISO/IEC 17043:2010 [6]. The 
team who organized this PT is an ISO/IEC 17043:2010 accredited PT provider [7]. 
 
3. Confidentiality  
Confidentiality of the identity of participants and their results towards third parties is 
guaranteed. 
 
4. Time frame  
The PT was announced on the EURL-Mycotoxins' webpage [7] and by direct mailing to 
NRLs, Official Control Laboratories (OCLs) and expert laboratories on 26 and 27 October 
2015. The registration for this PT was open until 06 January 2016 (Annex 9.1). The 
samples were dispatched between 22 and 23 February 2016 and the participants were 
given six weeks to analyse the samples and to report the results along with the 
questionnaire duly filled. The deadline for reporting the results was 04 April 2016. 
 
5. Material  
5.1 Preparation  
Three different teas and herbal products (black Assam tea, peppermint leaves and fennel 
seeds) were kindly supplied by the german association THIE - tea & herbal infusions 
Europe. These materials were milled to pass a 2 mm sieve using a Retsch ZM200 mill 
(Retsch GmbH, Haan, Germany). The acquired materials were shown to be blank. In 
order to resemble a natural contamination, three materials were spiked with suitable 
amounts of Datura stramonium (stems and seeds) extracts in methanol. In another 
three materials, the concentration of scopolamine was raised to approximate the 
proportion that can be found in other plant species and to provide various combinations 
of the analytes over the PT items. Batches of approximately 4 kg of the three teas and 
herbs were spiked with the respective methanol extracts following an in-house 
procedure1, each one at low and high contamination levels. Then, the materials were 
                                           
1 The procedure used was based on the dilution of the methanol extracts in t-butylmethylether, 
which then was used to bedew the material. This allowed obtaining a rather homogeneous 
moistened mix, which was then allowed to evaporate prior further processing. 
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thoroughly homogenised, packed in amber plastic bottles in 25 g portions and stored in 
the freezer until dispatch. The participants were also provided with blank matrices for 
method optimization and to prepare spiked samples. 
 
5.2 Homogeneity  
For homogeneity testing 10 units per material (2 black teas, 2 peppermint and 2 fennel 
materials) were selected randomly. Two independent determinations were performed per 
bottle using a liquid chromatography-isotope dilution tandem mass spectrometry 
detection (LC-ID-MS/MS) based method. Homogeneity was evaluated according to the 
ISO 13528:2015 standard [8]. The materials proved to be adequately homogeneous 
(Annex 9.2). 
 
5.3 Stability  
The stability study was conducted following an isochronous experimental design 
[9]; -70 °C was chosen as the reference temperature for sample storage. Stability was 
assessed at the following test temperatures: room temperature (≈20 °C), 4 °C 
and -18 °C. The periods of time considered in this study were: 14, 25 and 49 days. The 
stability was evaluated according to the requirements of the ISO 13528:2015 [8]. A 
linear regression was drawn for each tested temperature over the duration of the PT, 
and the significance of the slope departure from zero at 95 % confidence level was 
verified (Annex 9.3). The materials proved to be adequately stable at room 
temperature, 4 °C and  18 °C for the period between dispatch (t=0) and the submission 
date of the last results (t=49 days). An exception was noted for atropine in fennel at 
room temperature, which underwent a decrease in concentration of 18.6 % after 49 
days. Nevertheless, shipment of the PT items was carried out under cooling conditions 
and the participants were instructed to store the PT items at -18 °C until analysis; 
therefore, this finding is not expected to have any impact on the participants' 
performance. 
 
5.4 Distribution  
The test materials were dispatched in polystyrene boxes, containing cooling packs, on 22 
and 23 February 2016. The samples were mostly received within 24 hours after dispatch. 
 
Each participant received: 
a) nine test materials for analysis, packed in amber plastic bottles 
- Samples B001-100 and B101-200 – black tea 
- Samples P001-100 and P101-200 – peppermint leaves 
- Samples F001-100 and F101-200 – fennel seeds 
- Peppermint blank, Black tea blank and Fennel seeds blank 
b) five amber glass ampoules containing 
- Isotope labelled internal standard solution (ISTD mix) 
- Tropane Alkaloids standard solution (TA mix) 
- Spiking solutions specific for black tea, peppermint leaves and fennel seeds 
c) accompanying letter with instructions on sample handling and reporting (Annex 9.4) 
d) a sample receipt form (Annex 9.5) and 
e) laboratory specific reporting files with a lab code (by email). 
 
The materials were shipped such that 4 °C was not exceeded. Upon arrival, storage was 
required to be at -18 °C until analysis.  
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6. Instructions to participants  
The scope of the PT and the instructions for sample handling and reporting was 
communicated to the participants via an accompanying letter (Annex 9.4). The 
laboratories were required to report the concentrations of atropine and scopolamine (in 
µg/kg), as it was standard practice in their laboratory. Then, in the Questionnaire 
(Annex 9.6), participants were asked to mention whether the results were corrected 
for recoveries or not and provide the recoveries figures (in %).  
The results were reported by the participants using RingDat software, which is part of 
the ProLab software [10]. Laboratory specific files generated by the ProLab software 
were sent to each laboratory by email. A specific questionnaire was also included. The 
questionnaire was intended to provide further information on method-related aspects 
and laboratory details to allow insights on potential individual and general trends 
observed in the results for possible follow-up procedures. Method-related details and 
performance parameters such as chromatographic conditions, MRM transitions, S/N ratio 
of peak signals (as peak-to-peak, instead of RMS) and LOQs were requested. 
Participants received information on the required storage conditions and were 
encouraged to perform the analysis as soon as possible, to allow enough time for data 
treatment and to get acquainted with the reporting software. 
 
7. Reference values and their uncertainties  
The assigned values of the analytes in the test samples and their uncertainties were 
established by Exact-Matching Double Isotope Dilution Mass Spectrometry (EMD-IDMS) 
at JRC-Geel (Table 2). This methodology is considered to provide the highest degree of 
accuracy of the assigned values [11].  
 
Table 2 - Assigned values of the analytes and their associated expanded uncertainties in 
the tea and herbal infusion test items. 
Sample Analyte 
Assigned value 
(µg/kg) 
U (k=2) 
(µg/kg) 
Black tea 001-100 
Atropine 16.9 0.7 
Scopolamine 2.3 0.3 
Black tea 101-200 
Atropine 8.3 0.3 
Scopolamine 9.5 0.5 
Peppermint 001-100 
Atropine 9.5 0.3 
Scopolamine 1.5 0.1 
Peppermint 101-200 
Atropine 21.2 0.5 
Scopolamine 2.5 0.2 
Fennel 001-100 
Atropine 42.2 1.8 
Scopolamine 13.4 0.4 
Fennel 101-200 
Atropine 18.8 0.3 
Scopolamine 20.8 0.9 
 
U - expanded uncertainty of the assigned value 
 
The spiking solutions for the 3 matrices all had the same concentration. Following the 
spiking protocol mentioned in the accompanying letter (Annex 9.4), the resulting 
concentrations were: scopolamine – 14.6 µg/kg and atropine – 14.4 µg/kg. 
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8. Evaluation of results  
8.1 General observations  
Out of the 42 laboratories that received the PT samples, 33 reported back their results. 
Nine laboratories declined to send their results either due to a change of interest or time 
constraints. Eleven laboratories were NRLs for Mycotoxins, and 22 were expert 
laboratories. 
The laboratories were free to use their method of choice. An LC-MS/MS standard 
operating procedure (SOP) suitable for the determination of TAs in cereals was provided 
to laboratories that placed a request. This SOP could be used to analyse tea and herbal 
infusions after minor amendments. The method provided was developed, validated and 
used by the EURL for Mycotoxins. 
Only liquid chromatography coupled with mass spectrometric detection methods were 
used by the participants for the determination of the two TAs in tea and herbal infusions. 
This PT was organised in a way to resemble also a layout of a collaborative method 
validation study. Nine test items were supplied to the participants, and seven 
laboratories entirely followed the EURL-provided SOP. 
 
8.2 Scores and evaluation criteria  
Individual laboratory performance was assessed in terms of z-scores in accordance with 
ISO 13528:2015 [8]. 
 
z=        Equation 1. 
where: 
xlab is the measurement result reported by a participant 
Xref is the reference value (assigned value) 
σp is the standard deviation for proficiency assessment (target standard deviation) 
 
σp was calculated using the Horwitz equation, modified by Thompson [12] for analyte 
concentrations <120 µg/kg: 
 
- for analyte concentration <120 µg/kg 
 
        Equation 2. 
where: 
c = concentration of the measurand (assigned value, Xref, ) expressed as a dimensionless 
mass ratio, e.g. 1 µg/kg = 10-9, 1 mg/kg = 10-6 
 
The z-score compares the participant's deviation from the reference value with the 
target standard deviation accepted for the proficiency test, σp. The z-score is interpreted 
as follows: 
|z| ≤ 2  acceptable result 
2 < |z| < 3  questionable result 
|z| ≥ 3  unacceptable result 
 
8.3 Laboratory results and scoring  
The statistical evaluation of the results was performed using the ProLab software [10]. 
The robust mean and the reproducibility standard deviation were computed according to 
Algorithm A of ISO 13528:2015, and are given just for information purposes [8]. Z-
pσ
reflab Xx −
cp ⋅= 22.0σ
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scoring was calculated for scopolamine and atropine using the values assigned by EMD-
IDMS instead of the consensus values (robust mean). 
85.9 % of the results reported by the participants obtained acceptable z-scores (|z|≤ 2) 
whereas 6.7 % of the results fell into the unacceptable range with |z|≥ 3 (Figure 1) 
 
Figure 1 - Distribution of all z-scores across measurands/samples/laboratories. 
 
Figure 2 - Distribution of the z-scores for atropine (left) and scopolamine (right) across 
samples/laboratories.  
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The breakdown of the z-scores by analyte (Figure 2) shows that the laboratories' 
performance for atropine was slightly better than for scopolamine. This finding might be 
explained by the fact that scopolamine concentrations were in general lower or much 
lower than atropine, rendering the determination more demanding. 
Figures 3 and 4 provide an overview of the individual z-scores assigned to the results of 
atropine and scopolamine, respectively, in the tea and herbal infusion test materials. The 
longer the triangles, the larger were the differences to the assigned values. Blue 
triangles represent z-scores in the acceptable range, yellow triangles in the questionable 
range and red triangles in the unacceptable performance range. The corresponding 
scores are shown next to the triangles. 
 
Figure 3 – Individual laboratory z-scores for atropine across the 9 test items. B - black 
tea, F -  fennel and P – peppermint. 
 
The numerical values of the calculated z-scores are compiled in Tables 3 and 4. All z-
scores in the questionable performance range are shown with a yellow background, 
while z-scores indicating unacceptable performance are presented a with a light-red 
background. This mode of presentation allows for easy distinction between the two 
performance ranges, even on black-and-white prints. 
The graphical representations of the sigmoidal distribution of the results (µg/kg) for each 
combination of measurand/sample are given in Figure 5. Reported results are shown as 
bars. The green line corresponds to Xref; the green shadow covers the boundary of the 
reference interval (Xref ± uref), and the red lines mark the boundary of the target 
interval (Xref ± 2σ). Yellow bars represent results with |z-score| <3 while red bars 
represent unacceptable results. 
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Figure 4 – Individual laboratory z-scores for scopolamine across the 9 test items. B - 
black tea, F -  fennel and P – peppermint. 
 
Annex 9.7 shows the kernel density plots drawn for atropine and scopolamine across 
the nine test items. The confidence intervals of the robust means calculated from the 
participants' results overlap with the confidence intervals of the assigned values for all 
the analytes and matrix combinations. For the spiked samples, no uncertainty was 
calculated for the target value, as the spiking was done by the participants. The 
dispersion of the results approximates a Gaussian distribution (in green). The major 
mode is close to the assigned (reference) value and the robust mean calculated from the 
results of the participants. 
The robust standard deviations of the reported results for both TAs are also in good 
agreement with the target standard deviation (22 %). The HORRAT values are generally 
in the range from 0.7 to 1.4, with two exceptions (1.8 and 2.2 for low concentrations of 
scopolamine). Summaries of the statistical evaluation of the results for atropine and 
scopolamine in the test items are presented in Tables 5 and 6. The robust standard 
deviations ranged from 18.7 to 32.9 % for atropine and from 15.8 to 46.4 % for 
scopolamine. The highest standard deviation for atropine was observed in spiked black 
tea at the 14.4 µg/kg level while the highest standard deviation for scopolamine was 
observed in peppermint contaminated at the low level (2.5 µg/kg). 
The above evidence supports the assumption that the measurement of atropine and 
scopolamine in tea and herbs is sufficiently reliable in terms of precision and bias within 
the participants population. It can therefore be assumed that the methods available 
allow monitoring of tropane alkaloids at the target level of 10 µg/kg and even below for 
each alkaloid. 
Z-Score
-3 0 3 -3 0 3 -3 0 3 -3 0 3 -3 0 3 -3 0 3 -3 0 3 -3 0 3 -3 0 3
Sample
SAMPLE1B SAMPLE1F SAMPLE1P SAMPLE2B SAMPLE2F SAMPLE2P SPIKE-B SPIKE-F SPIKE-P
La
bo
ra
to
ry
2
4
5
7
13
14
15
18
19
21
23
24
25
27
28
30
31
33
34
35
36
37
38
40
41
42
44
45
46
47
50
52
53
17.9
4.9
22.6
86.7
31.5
51.6
4.1
79.5
28.8
4.4
3.9
54.3
14.1
75.7
5.0
35.4
-3.1
-3.6
-3.8 -4.1
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Table 3 - Analytical results and z-scores for atropine in the nine test items. B - black tea, F -  fennel and P – peppermint. 
Colour code: yellow – questionable, red – unacceptable 
 
Samples SAMPLE1B 
z-
score 
SAMPLE1F 
z-
score 
SAMPLE1
P 
z-
score 
SAMPLE2B 
z-
score 
SAMPLE2F 
z-
score 
SAMPLE2P 
z-
score 
SPIKE-B 
z-
score 
SPIKE-F 
z-
score 
SPIKE-P 
z-
score 
Lab/Unit µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  
2 15.97 -0.2 44.15 0.2 9.92 0.2 8.13 -0.1 19.87 0.2 21.66 0.1 13.90 -0.2 14.15 -0.1 14.81 0.1 
4 14.88 -0.5 42.22 0.0 7.41 -1.0 8.68 0.2 16.65 -0.5 17.40 -0.8 16.27 0.6 12.58 -0.6 10.86 -1.1 
5 19.10 0.6 51.60 1.0 11.30 0.9 9.30 0.5 22.70 0.9 25.10 0.8 15.90 0.5 16.20 0.6 16.20 0.6 
7 14.30 -0.7 51.60 1.0 10.10 0.3 8.50 0.1 22.90 1.0 18.80 -0.5 13.10 -0.4 17.30 0.9 13.60 -0.3 
13 17.40 0.1 40.50 -0.2 8.00 -0.7 8.50 0.1 17.70 -0.3 18.80 -0.5 7.10 -2.3 7.10 -2.3 5.90 -2.7 
14 9.50 -2.0 38.50 -0.4 4.70 -2.3 4.00 -2.4 16.10 -0.7 11.30 -2.1 9.60 -1.5 11.00 -1.1 5.50 -2.8 
15 17.10 0.1 45.50 0.4 9.30 -0.1 8.10 -0.1 18.40 -0.1 20.90 -0.1 13.40 -0.3 14.20 -0.1 13.00 -0.5 
18 17.29 0.1 51.90 1.0 12.04 1.2 7.23 -0.6 18.83 0.0 23.99 0.6 12.31 -0.7 14.82 0.1 10.83 -1.1 
19 22.00 1.4 46.70 0.5 9.80 0.2 14.90 3.6 20.20 0.3 21.40 0.0 20.20 1.8 14.10 -0.1 14.10 -0.1 
21 21.00 1.1 50.70 0.9 11.70 1.1 9.60 0.7 2.80 -3.9 25.80 1.0 17.10 0.8 15.60 0.4 17.60 1.0 
23 20.70 1.0 26.10 -1.7 9.90 0.2 13.70 2.9 16.30 -0.6 19.10 -0.4 16.30 0.6 11.50 -0.9 15.10 0.2 
24 20.94 1.1 49.56 0.8 9.86 0.2 8.52 0.1 24.10 1.3 27.71 1.4 20.46 1.9 17.48 1.0 20.55 1.9 
25 14.90 -0.5 68.60 2.8 9.50 0.0 6.60 -0.9 24.40 1.3 17.20 -0.9 19.80 1.7 17.60 1.0 18.50 1.3 
27 13.64 -0.9 69.24 2.9 3.56 -2.8 5.26 -1.7 21.39 0.6 9.54 -2.5 7.70 -2.1 15.07 0.2 12.40 -0.6 
28 17.00 0.0 53.60 1.2 7.70 -0.8 8.50 0.1 23.30 1.1 16.30 -1.0 13.80 -0.2 16.40 0.6 11.90 -0.8 
30 23.45 1.8 58.99 1.8 11.98 1.2 11.26 1.6 26.68 1.9 26.18 1.1 not tested  not tested  not tested  
31 not tested   45.64 0.4 4.98 -2.2 not tested   43.20 >4 5.86 -3.3 not tested   13.96 -0.2 7.82 -2.1 
33 17.80 0.3 46.70 0.5 9.70 0.1 9.60 0.7 20.10 0.3 21.20 0.0 12.80 -0.5 14.20 -0.1 14.00 -0.1 
34 25.20 2.2 55.10 1.4 7.48 -1.0 9.28 0.5 21.60 0.7 17.40 -0.8 5.20 -2.9 10.15 -1.4 9.55 -1.5 
35 10.30 -1.8 40.10 -0.2 7.20 -1.1 4.70 -2.0 17.60 -0.3 17.60 -0.8 8.50 -1.9 11.80 -0.8 5.30 -2.9 
36 10.32 -1.8 24.54 -1.9 9.73 0.1 24.84 >4 54.82 >4 27.20 1.3 7.08 -2.3 11.16 -1.0 8.17 -2.0 
37 13.20 -1.0 45.40 0.3 7.50 -0.9 6.70 -0.9 16.30 -0.6 18.30 -0.6 10.70 -1.2 12.40 -0.6 11.30 -1.0 
38 20.04 0.9 39.18 -0.3 9.60 0.1 9.92 0.9 18.20 -0.2 22.29 0.2 15.17 0.2 13.21 -0.4 12.58 -0.6 
40 11.11 -1.6 48.30 0.7 8.23 -0.6 6.36 -1.1 17.93 -0.2 19.04 -0.5 11.28 -1.0 13.31 -0.4 10.18 -1.3 
41 16.50 -0.1 44.49 0.2 10.45 0.5 8.62 0.2 20.78 0.5 23.26 0.4 14.38 0.0 13.34 -0.3 15.43 0.3 
42 16.30 -0.2 35.90 -0.7 9.60 0.1 9.40 0.6 15.40 -0.8 20.50 -0.1 3.20 -3.5 10.10 -1.4 1.80 -4.0 
44 17.00 0.0 52.00 1.1 10.00 0.3 8.90 0.3 24.00 1.2 27.00 1.3 11.00 -1.1 14.00 -0.1 10.00 -1.4 
45 not tested   48.60 0.7 10.50 0.5 not tested   22.20 0.8 23.80 0.6 not tested   15.50 0.3 13.40 -0.3 
46 15.80 -0.3 42.50 0.0 8.30 -0.6 8.20 -0.1 18.40 -0.1 18.50 -0.6 13.70 -0.2 13.70 -0.2 14.00 -0.1 
47 14.80 -0.6 37.50 -0.5 7.40 -1.0 7.50 -0.4 17.50 -0.3 15.40 -1.2 12.00 -0.8 12.00 -0.8 11.90 -0.8 
50 81.30 >4 908.90 >4 167.90 >4 14.80 3.5 397.40 >4 377.70 >4 46.30 >4 263.70 >4 189.30 >4 
52 20.30 0.9 49.59 0.8 8.79 -0.3 9.67 0.7 24.65 1.4 16.47 -1.0 14.30 0.0 16.56 0.7 13.90 -0.2 
53 16.00 -0.2 41.00 -0.1 < 10.00   < 10.00   20.00 0.3 18.00 -0.7 10.00 -1.4 10.00 -1.4 11.00 -1.1 
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Table 4 - Analytical results and z-scores for scopolamine in the nine test items. B - black tea, F -  fennel and P – peppermint. 
Colour code: yellow – questionable, red – unacceptable 
 
Samples 
SAMPLE1
B 
z-
score 
SAMPLE1F 
z-
score 
SAMPLE1P 
z-
score 
SAMPLE2
B 
z-
score 
SAMPLE2F 
z-
score 
SAMPLE2P 
z-
score 
SPIKE-B 
z-
score 
SPIKE-F 
z-
score 
SPIKE-P 
z-
score 
Lab/Unit µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  µg/kg  
2 11.15 >4 14.43 0.3 1.10 -1.2 18.07 >4 22.53 0.4 2.07 -0.8 23.54 2.8 15.39 0.3 14.20 -0.1 
4 < 2.00  11.70 -0.6 < 2.00  9.65 0.1 18.84 -0.4 < 5.00  13.86 -0.2 12.99 -0.5 10.87 -1.2 
5 2.50 0.5 14.00 0.2 1.60 0.3 9.60 0.0 21.40 0.1 2.40 -0.2 14.30 -0.1 13.80 -0.2 10.50 -1.3 
7 1.20 -2.1 12.20 -0.4 0.70 -2.4 5.90 -1.7 18.00 -0.6 1.50 -1.8 8.60 -1.9 12.50 -0.6 8.40 -1.9 
13 2.30 0.1 13.90 0.2 1.30 -0.6 11.10 0.7 21.10 0.1 2.40 -0.2 8.30 -2.0 7.20 -2.3 6.90 -2.4 
14 1.60 -1.3 14.10 0.2 0.70 -2.4 6.60 -1.4 19.90 -0.2 1.30 -2.2 11.20 -1.1 13.70 -0.3 8.10 -2.0 
15 2.10 -0.3 11.70 -0.6 1.10 -1.2 8.00 -0.7 17.20 -0.8 1.90 -1.1 12.60 -0.6 12.20 -0.7 12.20 -0.7 
18 1.74 -1.0 14.74 0.5 1.47 -0.1 7.14 -1.1 19.22 -0.3 3.80 2.3 10.67 -1.2 18.84 1.3 14.74 0.1 
19 2.40 0.3 12.80 -0.2 1.10 -1.2 8.90 -0.3 20.20 -0.1 2.70 0.3 12.10 -0.8 12.80 -0.6 12.60 -0.6 
21 2.40 0.3 10.00 -1.2 1.90 1.3 8.70 -0.4 17.80 -0.6 2.50 0.0 14.30 -0.1 10.80 -1.2 12.20 -0.7 
23 2.40 0.3 10.50 -1.0 11.80 >4 3.50 -2.9 15.60 -1.1 18.50 >4 3.09 -3.6 15.10 0.2 13.00 -0.5 
24 1.22 -2.1 9.76 -1.2 not tested   6.07 -1.7 14.69 -1.3 2.04 -0.9 13.11 -0.5 11.14 -1.1 9.87 -1.5 
25 1.80 -0.9 14.00 0.2 not tested  8.00 -0.7 19.80 -0.2 not tested  14.60 0.0 14.70 0.0 15.60 0.3 
27 3.04 1.6 15.56 0.7 2.25 2.3 10.41 0.4 20.99 0.1 4.97 >4 16.79 0.7 16.75 0.7 16.59 0.6 
28 < 5.00  10.20 -1.1 < 5.00  5.60 -1.9 14.80 -1.3 < 5.00  8.30 -2.0 9.90 -1.5 9.00 -1.7 
30 2.24 0.0 13.51 0.0 1.09 -1.2 9.47 0.0 21.00 0.1 2.29 -0.4 not tested  not tested  not tested  
31 not tested   17.20 1.3 < 0.20   not tested   12.72 -1.8 < 0.20   not tested   21.90 2.3 not tested   
33 < 4.00  11.40 -0.7 < 2.00  8.60 -0.4 18.70 -0.4 < 2.00  12.00 -0.8 12.40 -0.7 6.40 -2.5 
34 4.70 >4 15.50 0.7 2.09 1.8 14.50 2.4 19.80 -0.2 1.02 -2.7 6.13 -2.6 9.10 -1.7 5.93 -2.7 
35 1.80 -0.9 11.60 -0.6 1.10 -1.2 7.20 -1.1 19.10 -0.4 2.60 0.1 10.40 -1.3 12.20 -0.7 6.20 -2.6 
36 13.48 >4 19.84 2.2 1.64 0.5 3.09 -3.1 11.98 -1.9 3.67 2.1 6.12 -2.6 14.35 -0.1 9.86 -1.5 
37 1.70 -1.1 12.70 -0.2 1.00 -1.5 8.00 -0.7 19.20 -0.3 1.90 -1.1 12.00 -0.8 13.30 -0.4 12.20 -0.7 
38 1.92 -0.7 13.67 0.1 1.30 -0.6 10.17 0.3 21.95 0.3 2.32 -0.4 14.54 0.0 14.32 -0.1 12.14 -0.8 
40 1.66 -1.2 15.43 0.7 1.72 0.7 7.42 -1.0 17.16 -0.8 2.39 -0.2 10.20 -1.4 13.78 -0.2 8.27 -2.0 
41 3.00 1.5 13.47 0.0 2.12 1.9 13.35 1.8 23.46 0.6 4.67 3.9 16.99 0.8 14.21 -0.1 30.75 >4 
42 2.60 0.7 11.90 -0.5 1.00 -1.5 9.50 0.0 17.80 -0.6 2.10 -0.8 2.40 -3.8 10.60 -1.2 1.40 <-4 
44 2.00 -0.5 12.00 -0.5 1.80 0.9 9.40 -0.1 19.00 -0.4 2.70 0.3 9.50 -1.6 12.00 -0.8 9.50 -1.6 
45 not tested   14.20 0.3 1.30 -0.6 not tested   21.10 0.1 2.40 -0.2 not tested   13.40 -0.4 13.00 -0.5 
46 1.60 -1.3 10.80 -0.9 1.00 -1.5 7.80 -0.8 16.40 -1.0 1.70 -1.5 12.40 -0.7 11.80 -0.9 12.10 -0.8 
47 2.50 0.5 11.80 -0.5 1.40 -0.3 9.10 -0.2 18.00 -0.6 2.00 -0.9 13.30 -0.4 11.40 -1.0 14.50 0.0 
50 not tested   269.10 >4 18.40 >4 not tested   383.80 >4 32.60 >4 not tested   257.10 >4 128.00 >4 
52 2.83 1.1 13.21 -0.1 2.11 1.9 10.29 0.4 16.20 -1.0 10.31 >4 14.36 -0.1 11.19 -1.1 14.53 0.0 
53 < 5.00   16.00 0.9 < 5.00   11.00 0.7 25.00 0.9 < 5.00   10.00 -1.4 12.00 -0.8 14.00 -0.2 
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Table 5 - Summary statistics of the results for atropine in the nine test items. B - black tea, F -  fennel and P – peppermint. 
 
 
 
Units SAMPLE1B SAMPLE1F SAMPLE1P SAMPLE2B SAMPLE2F SAMPLE2P SPIKE-B SPIKE-F SPIKE-P 
No. of laboratories that 
submitted results  
31 33 33 31 33 33 30 32 32 
No. of participants (according to 
design)  
42 42 42 42 42 42 42 42 42 
Assigned (reference) value µg/kg 16.9 42.2 9.5 8.3 18.8 21.2 14.4 14.4 14.4 
Uncertainty of the assigned 
value (k=2) 
µg/kg 0.7 1.8 0.3 0.3 0.3 0.5   
 
Mean (robust) µg/kg 17.0 46.8 9.2 8.7 20.6 20.4 13.0 13.8 12.3 
Target s.d. µg/kg 3.7 9.3 2.1 1.8 4.1 4.7 3.2 3.2 3.2 
Reproducibility s.d. µg/kg 4.3 8.2 1.9 2.1 4.1 4.9 4.8 2.7 4.2 
Rel. SDPA % 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 
Rel. reproducibility s.d. (robust) % 25.5 19.3 20.4 25.4 21.7 23.2 32.9 18.7 28.7 
 
 
 
Table 6 - Summary statistics of the results for scopolamine in the nine test items. B - black tea, F -  fennel and P – peppermint. 
 
Units SAMPLE1B SAMPLE1F SAMPLE1P SAMPLE2B SAMPLE2F SAMPLE2P SPIKE-B SPIKE-F SPIKE-P 
No. of laboratories that 
submitted results  
30 33 31 30 33 32 29 32 31 
No. of participants (according to 
design)  
42 42 42 42 42 42 42 42 42 
Assigned (reference) value µg/kg 2.3 13.4 1.5 9.5 20.8 2.5 14.6 14.6 14.6 
Uncertainty of the assigned 
value (k=2) 
µg/kg 0.3 0.4 0.1 0.5 0.9 0.2 
   
Mean (robust) µg/kg 2.3 13.2 1.5 8.7 19.0 2.7 11.6 13.0 11.4 
Target s.d. µg/kg 0.5 3.0 0.3 2.1 4.6 0.6 3.2 3.2 3.2 
Reproducibility s.d. µg/kg 0.7 2.3 0.6 2.3 3.0 1.2 3.7 2.3 3.8 
Rel. SDPA % 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 
Rel. reproducibility s.d. (robust) % 31.3 16.8 38.4 24.1 14.4 46.5 25.7 15.7 26.5 
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Figure 5 – sigmoidal plots of individual laboratory results reported for atropine (ATROP) 
and scopolamine (SCOP) in the test items. B - black tea, F -  fennel and P – peppermint. 
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9. Evaluation of the questionnaire  
The questionnaire distributed to the participants has provided very useful information 
concerning the approaches and capabilities of the participating laboratories on the 
determination of tropane alkaloids in tea and herbal infusions. 
The questionnaire will be discussed in three sections: 
1) the first section will present the outcome of the Yes/No answers regarding the 
previous experience of the participants and general organisational matters: questions 2-
5 and 32-37 of Annex 9.6.  
2) the second section will deal with the outcome of the Yes/No answers concerning 
analytical aspects: questions 14-15, 21-22, 26-27, 29-31 and 38 of Annex 9.6. 
3) the third section will give a more extensive overview of the analytical conditions used 
by the participants for the determination of tropane alkaloids in tea and herbal products: 
questions 6-13, 16-20, 24-25 and 28 of Annex 9.6. 
 
9.1. Experience and organisational aspects  
In Table 7, the number of responses received and the percentage of Yes/No answers 
regarding the experience of the participants and general organisational matters are 
compiled. Sixty-seven percent of the participants declared to have prior experience in 
the analysis of TAs (Q.2). Among them, a vast majority was capable of determining only 
atropine and scopolamine and the most common matrices were cereals, cereal products 
(flour, bread, pasta), baby food formulas and animal feeds (Q.3). Five laboratories also 
declared to analyse TAs in tea and herbal tea. One laboratory extended its analytical 
scope to about 20 tropane alkaloids, and another could analyse 24 compounds, not 
specifying which. The experience of the laboratories on the analysis of TAs is relatively 
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limited. Most have less than two years of experience, with one laboratory mentioning 
five years of experience. The same number of laboratories (67 %) indicated that they 
could analyse other plant toxins (Q.4). Fourteen laboratories stated that they can 
analyse pyrrolizidine alkaloids while three can analyse opium alkaloids and 
glycoalkaloids. Six laboratories declared to be able to analyse ergot alkaloids, although 
these fall under the mycotoxin category. 
Regarding the satisfaction with the organisational aspects of the PT, the participants 
were asked to express their opinion on whether the time for reporting the results was 
adequate (Q.33), the time they spent for analysing the samples, treat the data and 
issuing the results (Q.35) and whether the amount of test items was sufficient for their 
needs (Q.34). Eighty-eight percent of the participants found the time for reporting the 
results (about 6 weeks) as appropriate. Almost all the participants required two or more 
days to finalise the analytical work. Ninety-four percent of the participants found the 
amount of sample dispatched (25 g) enough for performing the analysis (Q.34). 
Table 7 - Response to the questions related to the experience of the participants on the 
determination of tropane alkaloids in tea and organisational aspects of the PT 
 
 Q.2 Q.4 Q.14 Q.21 Q.26 Q.27 Q.30 Q.33 Q.34 Q.36 Q.37 
Response - NO 
Nr. 11 11 19 10 0 2 22 4 2 21 2 
% 33 33 59 30 0 6 71 13 6 78 7 
Response - YES 
Nr. 22 22 13 23 33 29 9 28 30 6 25 
% 67 67 41 70 100 94 29 88 94 22 93 
 
Although the participants were asked to submit a great deal of data (both analytical 
results and answers to the questionnaire) the experience with the RingDat software was 
positive (Q.34). Seventy-eight percent didn't experience any shortcoming. Still, some 
comments were received which are compiled below: 
- It was not possible to save all the data filled in the fields to answer the questions 11, 12, 13 
- Firewall problems 
- software very unstable; during the input repeated crashes 
- I prefer online forms. Execution of exe-files for non-admins does not always work. 
- This time, no problems 
- Several crashes when changing window size 
- Too long the overall procedure for reporting back the results. The error messages are not in English 
 
About 93 % of the participants found the instructions for performing the PT (Annex 9.6) 
adequate (Q.37). One participant commented that "the spiking part was not obvious to 
understand immediately" while another noted that the method that was supplied to 
some laboratories in the past was targeted for the determination of TAs in cereals and 
not in tea and herbs. Support to analytical issues was always provided to laboratories 
that requested it. The participants were informed about this PT through different routes, 
eventually cumulative (Q.32). According to the table below, most participants were 
informed by direct invitation through the mail from the European Commission CIRCABC 
database. Many of them were also notified by their respective NRLs or got to know about 
the PT during the annual EURL Mycotoxins workshop. 
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Information source about the PT TAs in tea and herbal infusions % 
Through the EURL Mycotoxins website 13 
During the EURL workshop for the NRLs on mycotoxins 18 
By invitation from the European Commission communication office 32 
By the NRL in your country 18 
By professional associates in your sector 8 
Other 11 
 
9.2. Analytical aspects  
The participants in the PT were asked whether the analytical method used for analysing 
TAs in tea and herbal tea was validated (Q.14, Table 7). About 59 % of the participants 
replied that they did not perform any assays in that regard. It is important to note that 
many laboratories have implemented the method just prior to participating in the PT 
and, therefore, they didn't have enough time to validate the method. Among those who 
performed the method validation, 80 % included the parameters: precision (mainly 
repeatability), linearity, LOD and recovery while 90 % also estimated the LOQ. None of 
them estimated the measurement uncertainty. 
Isotope-labelled internal standards for atropine and scopolamine are commercially 
available and were supplied to the participants along with the test items. Seventy 
percent of the participants answered that they use isotope dilution MS for quantification 
(Q.21). The majority of them (70 %) added the internal standards before the 
extraction, 3 % added the internal standards after the extraction and 21 % 
responded as "Non applicable" (Q.22). The first approach provides more benefits as the 
internal standards can correct the results simultaneously for the biases (e.g. loss) during 
the extraction step and compensate for the matrix effects that occur during MS analysis. 
All the participants have checked the integration of the chromatographic peaks (Q.26) 
while 94% also assessed the goodness of fit of the calibration curve in the region 
relevant for the quantification of the samples (Q.27). Additionally, the participants were 
asked to indicate whether they reported the results corrected for recoveries or not 
corrected for recoveries (Q.28). About 74 % of the participants stated that they did 
not correct the results for the recoveries. Nevertheless, as long as the participants added 
the internal standards to the samples before the extraction (Q.22) and, assuming they 
did an internal calibration quantification, then the obtained results were automatically 
corrected for the recoveries (biases). Taking this information into consideration, only 
19 % of the results might have been reported without correction for recoveries. 
Regarding the satisfaction of the participants with the experience running the PT, 71% 
declared that they did not have major difficulties analysing the distributed samples 
(Q.30). Due to a program bug, it was not possible to compile the type of difficulties the 
remaining laboratories might have undergone (Q.31). On average, the analyst 
responsible for conducting the PT had about eight years of experience with LC-MS/MS 
methods (Q.29). 
The participants were given the opportunity to raise general comments about the PT 
(Q.38). As listed below, the comments concern mainly clarifications related to the 
analytical protocol that was followed and difficulties posed by the matrices when 
quantifying scopolamine and atropine. Regarding the latter, it is a general opinion that 
the black tea sample was more difficult to analyse, sometimes hampering to send 
results. The analysis of scopolamine was mentioned twice as especially troublesome in 
these complex matrices. 
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- it was not possible to submit all the data. After saving, it was deleted automatically. 
- we used standard addition for quantification purposes 
- For the sample F012, 1g instead of 2g was weighted, in order to achieve measurements inside 
the region of the calibration curve. Thus, the reported values for S/N correspond to 1g of sample 
diluted with 29 mL extraction solvent. 
- The tea-matrix is difficult for Scopolamine, because there are a few ghost peaks. 
- We used the procedural standard calibration which automatically corrects for recovery losses as 
well as matrix effects 
- we had huge problems with black tea and weren't able to report results 
- S/N ratio: processing with MassLynx Software; Peak to Peak; number of blank (Sample P, B, F 
spike) was not given: we called it "1" for P, "2" for B, "3" for F 
- The secondary ion for the Internal Std was poor or non-existent for some matrices in particular 
the fennel. 
- We could not achieve repeatable and reproducible results for black tea because of matrix 
interferences. So we could not report results for black tea. Because we have to enter numbers in 
the form we increased the limits of detection and quantification and reported 0 as the amount for 
all samples. We did not determine the recoveries. In the form we entered 0 in all cases. We could 
not find sample codes on the blank samples used for spiking. So we entered 000 as sample code 
in the cases of spiked samples. 
- Samples were analysed on two occasions: Black and Fennel tea on 27/03/2016, Peppermint tea 
on 31/03/2016 
- Matrix suppression could not be calculated because ISTD was added at the beginning of the 
Sample prep. Analysis of the black tea sample was more difficult, compared to other samples. 
They were very extract rich and at times difficult to pass over SPE column. Resulting 
chromatograms were analysable, nonetheless 
- In Black Tea, it was not possible to quantify Scopolamine (due to matrix effects) 
 
9.3. Methods' overview 
Along with the analytical results, the participants in this PT also submitted a compilation 
of some validation figures of merit and a description of core methodological features. In 
Annex 9.8.1, the reported limits of quantification (LOQs), recoveries (%), matrix 
suppression (MatrixSup, %) and retention times (RT, min) for both atropine and 
scopolamine are shown. The figures reported for Sample1 B, F and P, were taken as 
representative for the matrices black tea, fennel and peppermint, respectively. As it can 
be seen in Figure 6, the vast majority of the reported LOQs for atropine and scopolamine 
fell below 5.0 µg/kg, with a significant number being also below 1.0 µg/kg. The 
methodologies employed relied mostly on a fairly simple sample preparation, mainly 
"dilute and shoot" (Annex 9.8.2, Question 8). 
The average recoveries considering the 3 matrices were 88 % for atropine and 91 % for 
scopolamine (see Figure 7), but with significant dispersion among the participants. Given 
the diversity of extraction methods applied (Question 7: shaking, QuEChERS, different 
solvent compositions and pH from acidic to alkaline), these figures fall within an 
acceptable range. Regarding the matrix effects, ionization suppression was mostly 
observed for both atropine and scopolamine with the instrumental response covering a 
range from about 20 to 80 %. 
An overall overview of the analytical methodologies employed (Annex 9.8.2) indicates 
that nine laboratories applied the EURL-developed method. However, two laboratories 
deviated slightly, using an analytical column other than the recommended 
(pentafluorophenyl stationary phase). Five laboratories applied the RIKILT SOP A1070 or 
the method described in Adamse, P; van Egmond H.P. (2010): Report 2010.011, which 
follows similar principles. Two laboratories followed the reference: Jandric et al., Food 
Additives and Contaminants 28 (9) (2011) 1205-1219, which is a QuEChERS-derived 
method and two other laboratories adopted the BfR-PA-Tee-2.0/2014 method. Fifteen 
laboratories stated that they used either an in-house developed method or the reference 
did not allow grouping them in any of the previous categories. All the laboratories used 
LC-MS/MS for separation and detection. The two most used methods (EURL and RIKILT) 
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generated equivalent results (not statistically different at a significance level of 0.05). 
Likewise, the results obtained using the calibration standards supplied by the EURL and 
those existing in the laboratories were not statistically different. 
 
Figure 6 – Histograms of the methods' LOQs for atropine and scopolamine in tea and 
herbal tea samples  
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Figure 7 – Histograms of methods' recoveries (%) for atropine and scopolamine in tea 
and herbal tea samples. 
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Histogram of  Scopolamine
Scopolamine Rec B = 223*5*Normal(Location=90.7553,
Scale=29.7897)
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10. Conclusions  
On request of DG SANTE, the EURL for Mycotoxins organised a PT aiming to assess the 
measurement capability of EU Member States' laboratories regarding the determination 
of tropane alkaloids (atropine and scopolamine) in tea and herbal infusions. 
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Forty-two laboratories registered for this PT, of which 33 participants representing 11 EU 
Member States submitted their results. More than half of the participants were German 
laboratories. 
Overall, more than 85 % of the z-scores were in the range of [-2,2], and more than 93 
% fell within the range of [-3,3]. For atropine, 87 % of the results fell within the 
acceptable range (|z| ≤ 2) while for scopolamine, 84 % of the results were in this range. 
The performance of the laboratories was, therefore, comparable for both analytes, 
despite the fact that scopolamine was generally present in much lower concentrations 
than atropine (lowest level 1.5 µg/kg). 
A matrix-wise evaluation of the z-scores for atropine indicated that the success rate (|z| 
≤ 2) was similar in black tea and peppermint (around 85 %) but higher in fennel (91 
%). For scopolamine, the rate of acceptable z-scores was the lowest in peppermint (75 
%) followed by black tea (83 %) and fennel (94 %). The lowest rate of acceptable z-
scores for atropine (83 %) was observed in black tea, which also contained the lowest 
concentration (8.3 µg/kg). The lowest rate of acceptable z-scores for scopolamine (67 
%) was observed in a peppermint sample containing 2.5 µg/kg while other samples with 
similar concentration (2.3 and 1.5 µg/kg) originated around 81 % acceptable z-scores. 
A vast majority of reported LOQs were below 5.0 µg/kg, some of them being even below 
1.0 µg/kg. All laboratories used LC-MS/MS in their determinations. Nine participants 
followed the analytical protocol supplied by the EURL, while two of them used a different 
analytical column than the recommended one. Five participants used the original or 
adapted RIKILT SOP A1070. No significantly different results (at the 95 % confidence 
level) were generated by the two most applied SOPs neither by the use of standards of 
different origins (supplied by the EURL or the laboratories' standards). 
The overall experience of the participants expressed in the questionnaire was very 
positive, including the organisational, technical and reporting aspects. 
The results of the PT support the conclusion that atropine and scopolamine can be 
reliably determined in tea and herbal infusions at the quantification levels set up in the 
EU Recommendation 2015/976. A variety of analytical protocols has shown to be 
adequate for the determination of tropane alkaloids in tea. The laboratories achieved a 
highly satisfactory performance despite their somewhat short experience in the field. 
Some had implemented their methods just prior to the PT and underwent limited 
validation.  
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List of abbreviations and definitions  
EURL  European Union Reference Laboratory 
IDMS  Isotope Dilution Mass Spectrometry 
ISO  International Organization for Standardization 
JRC  Joint Research Centre 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LOD  Limit of Detection 
LOQ  Limit of Quantification 
MS  Member States 
NRL  National Reference Laboratory 
OCL  Official Control Laboratory 
PT  Proficiency Test 
SOP  Standard operating procedure 
SDPA  Standard deviation for proficiency assessment 
s.d.  Standard deviation 
TA  Tropane alkaloids 
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9.2 Homogeneity test 
Homogeneity according to ISO 
13528:2015 
Black tea 
B001-100 
Black tea 
B001-100 
Black tea 
B101-200 
Black tea 
B101-200 
Atropine Scopolamine Atropine Scopolamine 
Mean 14.1 1.77 6.79 7.44 
σˆ  3.11 (22 %) 0.39 (22 %) 1.49 (22 %) 1.64 (22 %) 
0.3 σˆ (critical value) 0.933 0.117 0.448 0.491 
SX (standard deviation of sample averages) 0.404 0.178 0.371 0.416 
SW (within-sample standard deviation) 0.517 0.255 0.223 0.342 
SS (between-sample standard deviation) 0.172 0.000 0.332 0.339 
SS < 0.3 σˆ  Passed Passed Passed Passed 
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Homogeneity according to ISO 
13528:2015 
Peppermint 
P001-100 
Peppermint 
P001-100 
Peppermint 
P101-200 
Peppermint 
P101-200 
Atropine Scopolamine Atropine Scopolamine 
Mean 8.28 1.32 18.24 2.22 
σˆ  1.82 (22 %) 0.29 (22 %) 4.01 (22 %) 0.49 (22 %) 
0.3 σˆ (critical value) 0.547 0.087 1.204 0.147 
SX (standard deviation of sample averages) 0.289 0.287 0.672 0.345 
SW (within-sample standard deviation) 0.638 0.393 0.731 0.480 
SS (between-sample standard deviation) 0.000 0.072 0.429 0.060 
SS < 0.3 σˆ  Passed Passed Passed Passed 
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Homogeneity according to ISO 
13528:2015 
Fennel 
F001-100 
Fennel 
F001-100 
Fennel 
F101-200 
Fennel 
F101-200 
Atropine Scopolamine Atropine Scopolamine 
Mean 54.1 13.4 24.2 21.0 
σˆ  11.9 (22 %) 2.94 (22 %) 5.32 (22 %) 4.62 (22 %) 
0.3 σˆ (critical value) 3.568 0.883 1.596 1.387 
SX (standard deviation of sample averages) 0.793 0.299 0.740 0.576 
SW (within-sample standard deviation) 1.263 0.569 0.847 0.629 
SS (between-sample standard deviation) 0.000 0.000 0.434 0.366 
SS < 0.3 σˆ  Passed Passed Passed Passed 
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9.3 Stability study 
 
Sample - Black tea B101-200 
 
 
Scopolamine Atropine 
T (ºC) Slope 
Lower 
95 % * 
Upper 
95 % * 
Null 
slope 
Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
-18 -0.00815 -0.02352 0.00722 YES -0.00293 -0.01297 0.00711 YES 
4 -0.00193 -0.01904 0.01518 YES 0.00351 -0.01957 0.02660 YES 
20 -0.00426 -0.02207 0.01356 YES 0.00215 -0.01234 0.01665 YES 
* Upper and lower intervals of the regression slope at 95 % confidence level. 
 
 
 
 
 
Sample – Peppermint P101-200 
 
 
Scopolamine Atropine 
T (ºC) Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
-18 0.00167 -0.01292 0.01626 YES -0.01143 -0.04052 0.01767 YES 
4 -0.00266 -0.01592 0.01059 YES 0.00318 -0.04145 0.04781 YES 
20 0.00185 -0.00768 0.01139 YES -0.01804 -0.06513 0.02904 YES 
 
 
 
 
Sample – Fennel F101-200 
 
 
Scopolamine Atropine 
T (ºC) Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
-18 0.00906 -0.02618 0.04430 YES 0.00793 -0.02935 0.04521 YES 
4 0.00639 -0.01918 0.03197 YES -0.01848 -0.04055 0.00359 YES 
20 -0.01946 -0.04355 0.00463 YES -0.08208 -0.11278 -0.05138 NO 
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9.4 Accompanying letter 
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9.5 Acknowledgement of receipt form 
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9.6 Questionnaire 
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9.7 Kernel density plots 
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%
)
M
od
e 
2:
 
4.
70
 
µg
/k
g 
(4 
%
)
Sample: SAMPLE2B, Measurand: ATROP
µg/kg
2017.51512.5107.552.50
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 8.32 ± 0.32 µg/kg
Mean: 8.71 ± 0.77 µg/kg
M
od
e 
1:
 
8.
73
 
µg
/k
g 
(88
 
%
)
M
od
e 
2:
 
14
.
55
 
µg
/k
g 
(10
 
%
)
Sample: SAMPLE2B, Measurand: SCOP
µg/kg
20181614121086420
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Mean: 8.68 ± 0.84 µg/kg
Assigned value (Reference value): 9.54 ± 0.51 µg/kg
M
od
e 
1:
 
8.
98
 
µg
/k
g 
(92
 
%
)
M
od
e 
2:
 
13
.
68
 
µg
/k
g 
(5 
%
)
M
od
e 
3:
 
18
.
06
 
µg
/k
g 
(3 
%
)
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Sample: SAMPLE1F, Measurand: ATROP
µg/kg
0
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
U
pp
er
 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 42.23 ± 1.76 µg/kg
Mean: 46.78 ± 2.84 µg/kg
M
od
e
 
1:
 
25
.
00
 
µg
/k
g 
(6 
%
)
M
od
e 
2:
 
47
.
00
 
µg
/k
g 
(85
 
%
)
Sample: SAMPLE1F, Measurand: SCOP
µg/kg
250
Pr
ob
a
bil
ity
 
de
n
sit
y
Lo
w
er
 
lim
it o
f t
o
ler
an
ce
Up
pe
r 
lim
it o
f t
ole
ra
n
ce
Assigned value (Reference value): 13.41 ± 0.44 µg/kg
Mean: 13.23 ± 0.79 µg/kg
M
od
e 
1:
 
13
.
48
 
µg
/k
g 
(94
 
%
)
Sample: SAMPLE2F, Measurand: ATROP
µg/kg
0
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
e
r 
lim
it o
f t
o
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
c
e
Assigned value (Reference value): 18.84 ± 0.31 µg/kg
Mean: 20.57 ± 1.42 µg/kg
M
od
e
 
1:
 
2.
80
 
µg
/k
g 
(3 
%
)
M
o
de
 
2:
 
18
.
40
 
µg
/k
g 
(88
 
%
)
Sample: SAMPLE2F, Measurand: SCOP
µg/kg
0
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Mean: 19.00 ± 1.04 µg/kg
Assigned value (Reference value): 20.75 ± 0.91 µg/kg
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Sample: SAMPLE1P, Measurand: ATROP
µg/kg
200
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 9.46 ± 0.33 µg/kg
Mean: 9.19 ± 0.68 µg/kg
M
od
e 
1:
 
4.
68
 
µg
/k
g 
(9 
%
)
Sample: SAMPLE1P, Measurand: SCOP
µg/kg
420
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 1.49 ± 0.08 µg/kg
Mean: 1.48 ± 0.22 µg/kg
M
od
e 
1:
 
1.
18
 
µg
/k
g 
(92
 
%
)
Sample: SAMPLE2P, Measurand: ATROP
µg/kg
500
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 21.17 ± 0.52 µg/kg
Mean: 20.40 ± 1.71 µg/kg
Sample: SAMPLE2P, Measurand: SCOP
µg/kg
50
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
nc
e
Assigned value (Reference value): 2.52 ± 0.19 µg/kg
Mean: 2.66 ± 0.45 µg/kg
M
od
e 
1:
 
2.
21
 
µg
/k
g 
(89
 
%
)
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Sample: SPIKE-B, Measurand: ATROP
µg/kg
35302520151050-5
Pr
ob
ab
ilit
y 
de
n
sit
y
Lo
w
er
 
lim
it o
f t
ole
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 14.44 µg/kg
Mean: 12.97 ± 1.74 µg/kg
M
od
e 
1:
 
13
.
32
 
µg
/k
g 
(97
 
%
)
Sample: SPIKE-B, Measurand: SCOP
µg/kg
3532.53027.52522.52017.51512.5107.552.50-2.5
Pr
ob
a
bil
ity
 
de
n
sit
y
Lo
w
er
 
lim
it o
f t
ole
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Mean: 11.58 ± 1.39 µg/kg
Assigned value (Reference value): 14.57 µg/kg
M
od
e 
1:
 
12
.
54
 
µg
/k
g 
(97
 
%
)
M
o
de
 
2:
 
23
.
54
 
µg
/k
g 
(3 
%
)
Sample: SPIKE-F, Measurand: ATROP
µg/kg
250
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
ler
an
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Assigned value (Reference value): 14.44 µg/kg
Mean: 13.78 ± 0.95 µg/kg
Sample: SPIKE-F, Measurand: SCOP
µg/kg
250
Pr
o
ba
bi
lity
 
de
n
s
ity
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
ler
an
c
e
Mean: 13.03 ± 0.81 µg/kg
Assigned value (Reference value): 14.57 µg/kg
M
od
e 
1:
 
12
.
65
 
µg
/k
g 
(94
 
%
)
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Sample: SPIKE-P, Measurand: ATROP
µg/kg
200
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Mean: 12.30 ± 1.47 µg/kg
Assigned value (Reference value): 14.44 µg/kg
Sample: SPIKE-P, Measurand: SCOP
µg/kg
3020100
Pr
ob
ab
ilit
y 
de
n
si
ty
Lo
w
er
 
lim
it 
of
 
to
le
ra
n
ce
Up
pe
r 
lim
it 
of
 
to
le
ra
n
ce
Mean: 11.40 ± 1.38 µg/kg
Assigned value (Reference value): 14.57 µg/kg
M
od
e 
1:
 
12
.
48
 
µg
/k
g 
(94
 
%
)
M
od
e 
2:
 
30
.
81
 
µg
/k
g 
(3 
%
)
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9.8. Experimental details 
9.8.1. Method performance characteristics 
 
Lab Sample LOQ 
(µg/kg) 
Atrop 
LOQ 
(µg/kg) 
Scop 
Rec (%) 
Atrop 
Rec (%) 
Scop 
MatrixSup 
(%) Atrop 
MatrixSup 
(%) Scop 
RT (min) 
Atrop 
RT (min) 
Scop 
2 
Sample1 B 5.0 5.0 100 100 0.23 0.23 5.80 4.78 
Sample1 F 1.0 1.0 100 100 0.8 0.8 5.80 4.78 
Sample1 P 1.0 1.0 100 100 0.64 0.64 5.80 4.78 
4 
 
Sample1 B 5.0 5.0   5.08 6.86 6.92 6.54 
Sample1 F 5.0 5.0   22.21 11.31 6.92 6.54 
Sample1 P 5.0 5.0   5.72 16.2 6.92 6.54 
5 
 
Sample1 B 2.5 2.5 106 97 1.01 0.95 10.40 7.40 
Sample1 F 2.5 2.5 106 97 1.11 1.08 10.40 7.40 
Sample1 P 2.5 2.5 106 97 0.8 0.52 10.40 7.40 
7 
 
Sample1 B 2.5 2.5 110 93   2.50 2.20 
Sample1 F 2.5 2.5 110 93   2.50 2.20 
Sample1 P 2.5 2.5 110 93   2.50 2.20 
13 
 
Sample1 B 0.5 0.5 119.9 111.7 46.8 32.2 7.30 6.00 
Sample1 F 0.5 0.5 100.8 92 46 25.9 7.30 6.00 
Sample1 P 0.5 1.0 94.9 98 13.9 4.9 7.20 5.90 
14 
 
Sample1 B 0.3 1.0 80 85 22 33 6.90 2.70 
Sample1 F 0.2 0.5 80 85 43 61 6.90 2.70 
Sample1 P 0.5 0.5 80 85 18 36 6.90 2.70 
15 
 
Sample1 B 0.2 0.2 23 30 23 30 8.27 7.94 
Sample1 F 0.2 0.2 69 70 69 70 8.27 7.95 
Sample1 P 0.2 0.2 88 53 88 53 8.27 7.95 
18 
 
Sample1 B 0.3 0.3 105.7 107.2 39.8 26 7.97 6.85 
Sample1 F 0.3 0.3 84 83.4 58.7 50.7 8.04 6.91 
Sample1 P 0.3 0.3 90.3 79.1 26.3 15.11 8.00 6.88 
19 
 
Sample1 B 0.5 0.5 100 100 4.1 1.8 9.00 7.00 
Sample1 F 0.5 0.5 100 100 36.6 46.5 9.00 7.00 
Sample1 P 0.5 0.5 100 100 25.8 35.6 9.00 7.00 
21 
 
Sample1 B       8.61 6.65 
Sample1 F       8.63 6.65 
Sample1 P       8.61 6.65 
23 
 
Sample1 B 5.0 5.0 100 100 80 80 2.96 2.76 
Sample1 F 5.0 5.0 120 120 60 60 2.96 2.76 
Sample1 P 5.0 5.0 80 80 60 60 2.96 2.76 
24 
 
Sample1 B 1.3 0.4 79 52 0.54 0.56 8.32 4.29 
Sample1 F 1.6 0.4 130 76 0.48 0.50 8.42 4.36 
Sample1 P 1.6 0.8 117 64 0.42 0.44 8.31  
25 
 
Sample1 B 0.1 0.3 64 117 36 24 6.30 5.30 
Sample1 F 0.1 0.3 21 112 34 27 6.20 5.20 
Sample1 P 0.1 0.3 20  24  6.20  
27 
 
Sample1 B   71.2 108.4   3.72 3.89 
Sample1 F   74.6 100.1   4.33 4.47 
Sample1 P   134.8 88   4.09 4.16 
28 
 
Sample1 B 5.0 5.0 80 60 0.7 0.80 8.30 7.10 
Sample1 F 5.0 5.0 100 60 1 1.20 8.30 7.10 
Sample1 P 5.0 5.0 80 70 0.9 0.70 8.30 7.10 
30 
 
Sample1 B 1.0 1.0 100 100   2.99 2.46 
Sample1 F 1.0 1.0 100 100   2.94 2.42 
Sample1 P 1.0 1.0 100 100   2.94 2.37 
31 
 
Sample1 B 0.1 0.2     4.40 2.80 
Sample1 F 0.1 0.2 78 149.8 47.9 47.8 4.40 2.80 
Sample1 P 0.1 0.2 44.2 72.1 82 78 4.40 2.80 
33 
 
Sample1 B 4.0 4.0   65.3 91.9 4.73 2.36 
Sample1 F 4.0 4.0   104.3 111.3 4.71 2.35 
Sample1 P 4.0 4.0 90.1 78.1 91.7 159.1 4.71 2.27 
34 
 
Sample1 B 2.0 2.0 44 69 49 66 2.63 1.84 
Sample1 F 2.0 2.0 57 69 61 67 2.63 1.84 
Sample1 P 2.0 2.0 57 145 63 140 2.63 1.84 
35 
 
Sample1 B 1.0 1.0     7.06 3.75 
Sample1 F 1.0 1.0     7.06 3.74 
Sample1 P 1.0 1.0     7.08 3.77 
36 
 
Sample1 B 0.6 0.6 52.83 40.82 81 44.6 4.28 3.47 
Sample1 F 0.6 0.6 79.23 97.36 61.27 80.72 4.2 3.42 
  
46 
Sample1 P 0.6 0.6 61.56 60.5 50.17 20.15 4.21 3.42 
37 
 
Sample1 B 0.1 0.1 100 100   7.03 4.69 
Sample1 F 0.1 0.1 100 100   7.02 4.69 
Sample1 P 0.1 0.1 100 100   7.03 4.69 
38 
 
Sample1 B 4.0 4.0 175 111 13 37 4.37 3.56 
Sample1 F 2.0 2.0 150 134 43 52 4.37 3.56 
Sample1 P 2.0 2.0 118 104 31 46 4.37 3.56 
40 
 
Sample1 B 0.1 0.4 75.4 56.9 51.9 41.3 8.16 6.40 
Sample1 F 0.1 0.4 83.4 80.3 90.6 50.6 7.89 6.41 
Sample1 P 0.1 0.4 69 80.7 50.5 24.6 7.88 6.44 
41 
 
Sample1 B 0.2 0.2 97 128 78.3 77.5 2.38 2.03 
Sample1 F 0.2 0.2 93 123 68.8 83.3 2.36 2.02 
Sample1 P 0.2 0.2 121 235 81.5 87.1 2.39 2.04 
42 
 
Sample1 B 2.0 2.0 82 87   6.32 5.70 
Sample1 F 2.0 2.0 105 104   6.30 5.69 
Sample1 P 2.0 2.0 90 96   6.31 5.71 
44 
 
Sample1 B 1.0 1.0       
Sample1 F 1.0 1.0       
Sample1 P 1.0 1.0       
45 
 
Sample1 B 300 300       
Sample1 F 1.0 1.0   74 77 10.10 8.70 
Sample1 P 1.0 1.0   74 82 10.10 8.70 
46 
 
Sample1 B 0.5 0.5   24.1 25.6 8.84 8.10 
Sample1 F 0.3 0.3   32.2 42.4 8.84 8.09 
Sample1 P 0.5 0.5   39.7 26.9 8.67 8.06 
47 
 
Sample1 B 1.0 1.0 7.6 9.6   6.57 5.46 
Sample1 F 1.0 1.0 88.4 63.3   6.55 5.45 
Sample1 P 1.0 1.0 29.1 37.8   6.54 5.65 
50 
 
Sample1 B 5.0 5.0 88 88 57 58 4.10 3.60 
Sample1 F 5.0 5.0 88 88 53 64 4.10 3.60 
Sample1 P 5.0 5.0 88 88 51 82 4.10 3.60 
52 
 
Sample1 B 1.0 1.0 116 96 51 54 5.05 4.06 
Sample1 F 1.0 1.0 108 85 76 84 5.06 4.08 
Sample1 P 1.0 1.0 96 103 40 49 5.05 4.04 
53 
Sample1 B 10 10 108 96   9.50 7.00 
Sample1 F 10 10 108 96   9.50 7.00 
Sample1 P 10 10 108 96  0.23 9.50 7.00 
 
Atrop – atropine; Scop - scopolamine 
 
 
9.8.2. Analytical conditions 
 
Lab Q.6 
Reference of the SOP used 
Q.7 
Extraction details 
Q.8 
Concentration
/clean-up 
Q.9 
Solvent to 
sample ratio 
Q.10 
Mass fraction 
injected 
2 Journal of Chromatography A 
Determination of tropane 
alkaloids atropine and 
scopolamine by liquid 
chromatography- mass 
spectrometry in plant organs of 
Datura species 
1 min. vortex, 20 min 
sonication in: 300 mL MeOH 
+ 200 mL H2O + 0.5 mL 
FormAc 
Filtration; 
Dilute and 
Shoot 
1g in 20 ml 0.0001 
4 Sample preparation procedure for 
the analysis of tropane alkaloids 
in food and feed by LC-MS/MS 
extraction with 0.4 % formic 
acid in methanol/water 
60/40, v/v 
only 
centrifugation 
and filtration 
1 g  sample 
extracted with 
20 ml extraction 
solvent 
10 µl filtrate 
from extract 
derived from no. 
9 injected for LC-
MS/MS analysis 
5 Adamse, P.; Egmond, H.P. van; 
Noordam, M.Y.; Mulder, P.P.J.; 
Nijs, W.C.M. de, Tropane 
alkaloids in food: poisoning 
incidents, Quality Assurance and 
Safety of Crops & Foods 6 
(2014)1. p. 15 - 24. 
stir 45 min, pH 9, Ammonium 
carbonate  / acetonitrile 16/ 
84 
Bondesil PSA 
40 µm 
25/5 2.5 g / 25 ml / 
1ml evaporated 
to dryness / 
reconstituted 5 / 
injected 10 µl 
7 Detection of ergot and tropane 
alkaloids by LC-MS/MS 
extraction could be done in 
about 2h, modified quechers 
/ 4g (+/- 0,02 g) of sample / 
30 ml Acetonitrile/ H2O + 2.1 
mmol/L ammonium 
modified 
quechers 
4 g of sample 
30 ml of 
solvent(with 
25.2 mL organic 
solvent) =6.3 
meq= 4 g of 
sample 30 ml of 
solvent (with 
25.2 mL of 
organic solvent)* 
  
47 
carbonate (84/16, v/v) / 45 
min rotate overhead / Add 
salts MgSO4 (4g)/NaCl (1g) / 
Centrifuge for  10,000 rpm 
for 5 min / 2 mL of 
supernatant through a 0.2 
um PTFE syringe filter / 
standard addition with 5 
microl of 100 ppb 
1 microl injection 
13 Draft protocol given by EURL 
after registration for PT 
Solvent: 
methanol/water/formic acid 
39:60:1; "head over head" 
extraction for 1 hour 
dilute and 
shoot 
10 0.002 
14 extraction from matrix by 0.05M 
H2SO4, centrifugation, 
supernatant pH adjustment to 9-
10 with ammonia, extraction with 
ethyl acetate, EtOAC evaporation, 
dissolution, centrifugation, 
injection 
extraction by agitation 
(vortex 10s, overhead 
15min) and sonication 
15min, 0.05M H2SO4 
pH adjustment 
to 9-10, liquid-
liquid 
extraction with 
ethyl acetate, 
evaporation of 
the EtoAc 
phase, 
dissolution and 
high-speed 
centrifugation, 
20 ml to 2 g 1 mg 
15 RIKILT SOP for TAs in cereals and 
cereal products, EFSA project 
30 minutes shaking. 
Extraction solvent 
methanol/water/formic acid 
solution (75/25/0.4%) 
SPE clean-up 
using Strata X-
C cartridges 
4g/40ml 4g/40ml, 5ml for 
SPE, made up in 
0.5ml = 1g/ml. 
Injection 2ul, 
meq= 0.002g 
(2mg) 
18 SOP provided by the EC Joint 
Research Centre, IRMM, EURL 
Mycotoxins 
Extraction time: 1hour 
shaking, 1 min vortex, 
methanol/water/formic acid 
39/60/1 
extract, dilute 
and shoot. No 
clean up, just 
filter with 
0.45um 
membrane 
2g of sample, 
20 mL 
extraction 
solvent 
meq=(2/20)x0.0
10 
19 Jandric et al.: Development of a 
liquid chromatography-tandem 
mass spectrometric method for 
the determination of tropane 
alkaloids and glycoalkaloids in 
crops. Food Additives and 
Contaminants Vol 28 (9), 2011, 
1205-1219 
European Food Safety Authority 
(EFSA): Scientific Opinion on 
Tropane alkaloids in food and 
feed. EFSA Journal 
2013;11(10):3386 
5 Minutes, Centrifugation non 1/3.25  
21 TAs are extracted from solid 
matrices with an acidic 
aqueous/methanolic solution. The 
extracts are purified and 
concentrated by means of solid 
phase extraction on a polymeric 
strong cation exchange cartridge. 
Tea infusions are purified and 
concentrated by means of solid 
phase extraction on a polymeric 
strong cation exchange cartridge. 
The purified extract is analysed 
by LC-MS/MS. 
The test sample size is 4 g. 
IS is added and 40 ml of 
extraction solution 
(methanol/water/formic acid 
solution (75/25/0.4%) are 
added. Extraction is carried 
out for 30 min on a rotary 
tumbler and the samples are 
centrifuged for 15 min at 
3500 rpm. 
SPE with Strata 
X-C 
10:1 2.4 mg 
23 FAC Vol 28, No. 10, October 
2011, 1405-1423 Screening of 
plant toxins in food, feed and 
botanicals using full-scan high 
resolution mass spectrometry, 
Mol et. al 
shaking dilute and 
shoot 
100 0.0000125 
24 Ergot alkaloids in Feed by HPLC-
MS/MS, BfR Berlin 
30 minutes shaking, solvent-
mixture: 90 % Methanol + 
10 % Water + 0.4 % formic 
acid 
concentration 
of spike: 0.5 
ng/ml; clean-
up: SPE Strata-
X 
20 ml solvent to 
0.5 g sample 
0.5 g sample 
extracted with 20 
ml solvent, then 
2 ml over SPE 
Strata-X, 
evaporated to 
dryness, 
  
48 
reconstituted 
with 2 ml 
solvent, 5 µl 
injected for LC-
MS analysis 
25 IRMM method from EURL 
"Determination of tropane 
alkaloids in cereals and cereal 
products by LC-MS/MS" 
shaking in 
methanol/water/formic acid 
39/60/1 for 1 hour 
centrifugation, 
supernatant 
was used for 
analysis 
10 meq=(2/20)x0.0
10 
27 In house method based on 
modified QuEChERS procedure. 
Addition of internal standard was 
used for detection, quantification 
and recovery by LC-MS/MS. 
Vortex-mixing 3x2minutes, 
automatic shaker for 2 
hours; 10 mL v:v 50:50 
0,5% Formic acid in 
water:acetonitrile. 
QuEChERS 
(MgSO4+NaCl), 
dSPE 
(MgSO4+PSA) 
  
28 EURL method 2g with 
methanol/water/formic acid 
39:60:1 / shaker for 1 hour / 
centrifuge and inject 
just dilute 1:10 
compared to TA 
in cereals 
10 0.0001 
30 For this proficiency test we used 
the Method from the EURL 
Mycotoxins. Before we used 
Quechers 
60 minutes on a shaker no 20 ml solvent 
and 2 g Sample 
0.001 
31 Deutsche Lebensmittelrundschau, 
Oktober 2015 page 418 
30 minutes (methanol/water 
60/40%) 
filtration 
Chromafil Xtra 
PA 0.45 um 
10 4 
33 ADAMSE, P. u. H.P. VAN EGMOND 
(2010): Tropane alkaloids in 
food, RIKILT - Institute of Food 
Safety, Report 2010.011 
methanol/water/formic acid 
(60+40+0,4) / 30 min 
shaking 
Dilute and 
Shoot 
sample mass: 2 
g ; volume of 
solvent: 20 ml 
0.2 mg 
34 ADAMSE, P; H. P. VAN EGMOND 
(2010): Tropane alkaloids in 
food, RIKILT - Institute of Food 
Safety, Report 2010.011 
extraction time: 30 sec / 
Ultraturax  MeOH (600ml) / 
H2O (400ml) / formic acid 
(4ml)  / Ultraturax solvent 
composition: MeOH/H2O 
centrifugation / 
filtration 0.2µm 
10 (2.5/25) x (1/5) 
x 0.1 = 5 mg 
35 2.5 g homogenized sample; add 
25 ml Extraction solvent; 
Blending for 30 Min.; 
Centrifugation for 10 Min. 4400 
rpm; Filtration with syringe filter 
0.2 µm; Dilution 1/20 with water: 
5 µl injection to LC-MS/MS 
Blending for 30 Min.; 
Extraction solvent: MeOH 
600 ml + Water 400 ml + 
Formic acid 4 ml 
Filtration and 
Dilute 
2.5 g/25 ml 2.5 g/25 ml; 
Dilution 1/20; 
Inj. 5µl = 0.025 
mg 
36 Analysed as per method supplied As per method supplied As per method 
supplied 
2 g/20 ml (2/20)x (1/0.5) x 
0.02 
37 acid extraction, SPE, drying of 
sample, reconstitution, LC-MS/MS 
30 min, 0.05 M H2SO4, 
sonication 
SPE 40 ml solvent 
for 2 g sample 
mass 
 
38 Your Method 1h, shaking, 
Methanol/Water/formic acid 
39/60/1 
Dilute and 
Shoot 
1g Sample / 10 
ml Solvent 
2 g sample 
extracted with 20 
mL solvent. 
Then, 5 µL 
injected for LC-
MS analysis. 
meq=(2/20) x 
0.005 
40 RIKILT SOP A1070 (modified) 15 min, blending, methanol / 
water (60:40) + formic acid 
(0.4 %) 
Dilute and 
Shoot 
4 0.002 
41 EURL method provided was used extraction time 1,5 hours / 
60:39:1 water: 
methanol:formic acid (see 
EURL method provided) 
None 20:2 (solvent: 
ml : sample g) 
meq = (2/20) * 
0.002= 0.0002 
42 In house method (own 
development) 
60% methanol with 0.4% 
formic acid, 45 min, 
sonication 
dilute and 
shoot 
2g in 20 mL 0.025 mg 
44 BfR-PA-2.0 n.s. n.s. n.s. 1g sample, 20 ml 
solvent, SPE with 
entire extract, 
reconst. in 1 mL, 
Injection of 5 mL 
45 http://www.bfr.bund.de/cm/343/
bestimmung-von-
pyrrolizidinalkaloiden.pdf 
15 min sonication (twice); 
0,05 M sulfuric acid 
C18 10 2 
46 SOP for analysis of TAs in dry 
tea, in house validated (no SOP 
number) 
30 min extraction with 
methanol/water/formic acid 
75/25/0.4 v/v/v 
SPE using 
strong cation 
exchange (150 
2 g sample and 
20 ml solvent 
2 g extracted 
with 20 ml 
solvent, 5 ml 
  
49 
mg/6 cc) extract cleaned 
by SPE, in 500 
uL solvent, 2 ul 
injected. meq =  
(2/20) x (5/0.5) 
x 0.002  =  2 mg 
47 In-house developed method 15 min extraction by 
sonication in Methanol : 
Acetonitrile 1 : 1 [v : v] 
SPE: ion 
exchange 
(SCX) 
10 mL solvent, 
1g sample 
meq = 
(1/10)*5/1)*0,0
1 = 5mg 
50 Jandric et al.(2011); Food 
Additives and Contaminants 28 
(9), 1205-1219 
30 min, shaking, Methanol + 
Water (60+40) + 0.4 % 
formic acid 
dilution 2.5 g in 25 ml 0.5 mg 
52 EURL method - Determination of 
tropane alkaloids in cereals and 
cereal products by liquid 
chromatography-tandem mass 
spectrometry 
1h, shaker, 
Methanol/Water/Formic acid 
(39:60:1, v/v) 
dilute and 
shoot 
20 mL, 1 g 0.5 mg 
53 internal method 30min, shaking/sonication. 
Solvent: 1/3 acetic acid; 2/3 
methanol, filtration 
chemical 
precipitation by 
polarity 
gradient, 
followed by 
membrane 
filtration 
2 g/20 ml 0.001 
 
Lab Q.11 
Type of separation 
Q.12 
Type of detecton 
Q.13 
Transitions, ratio and CID 
Q.23 
Calibrant 
Q.25 
* 
2 ZORBAX Extend C18 4,6x100mm, 
3,5µm 
Agilent 6460 Triple Quad 
LC/MS; ESI +; Capilary 
voltage 3000V, 
dessolvation Temp. 
370°C 
Atropine: 290,2-->124,1; 290,2--
>103 
Scopolamine: 304-->138; 304--
>156,1 
Our own SPS 
4  Waters, Acquity UPLC BEH C18 
150x2.1 mm; 1.7 µm. Eluent A: 0,1 % 
formic acid in water. Eluent B: 0,1 % 
formic acid in acetonitrile. gradient 
elution. 30 °C; 0,2 ml/min; 10 ml Inj 
Agilent QQQ 6460, ESI 
positive, Capillary 
voltage 3000 V, 300 °C 
Atropine: 290 > 124  CE 20 eV,  
290 > 93 CE 30 eV / Atropine d3 
293 > 127 CE 20 eV, 293 > 93 CE 
30 eV / Scopolamine 304 > 156 
CE 10 eV, 304 > 138  CE 18 eV / 
Scopolamine d3 307 > 159 CE 10 
eV,  307 > 141 CE 18 eV 
Our own SPS 
5 cfr. Methode Cereal Products cfr. Methode Cereal 
Products 
cfr. Methode Cereal Products Our own SPS 
7 reversed phase: Waters Kinetex EVO 
C18 column  1.7microm 100 x 2.1 mm 
40°C 
1 microl injection 
0.5 mL/min of mobile phase: ACN and 
H20 w ith 
ammoniak buffer 
. 40°C. 1 microl injection. 0.5 mL/min 
of mobile phase: ACN and H20 w ith. 
ammoniak buffer. 1.7ìm 100 x 2.1 mm. 
40°C. 1 microl injection. 0.5 mL/min of 
mobile phase: ACN-H20 w ith. 
ammoniak buffer 
HPLC_MS/MS XEVO TQ-S 
WATERS 
ESI+ 
CV: 1 kv 
Desolv temp: 450 °C 
. ESI+. CV: 1 kv. Desolv 
temp: 450 °C. ESI+. CV: 
1 kv. Desolv temp: 450 
°C 
Atropine Q124.0 (25V) -- C93.0 
(30V) Scopolamine Q138.0 (20V) 
-- C156.0 (15V). Scopolamine 
Q138.0 (20V) -- C156.0 (15V). 
Scopolamine Q138.0 (20V) -- 
C156.0 (15V) 
Supplied 
along with 
the PT 
samples 
SPS 
13 Column: Supelco Ascentis Expres F5, 
10 cm x 2,1 mm; 2,7 um MF: A - 0,1% 
FA/water, B - 0,1% FA/acetonitrile; 
flow rate: 0,3 ml/min; column 
temperature: 40 C deg; Injection 
volume: 20 ul 
LC-QQQ Agilent 6460, 
ESI + JetStream; Gas 
Temp 325°C; Gas Flow 
10 l/min; Nebulizer: 25 
psi; Sheath Gas Temp 
400°C; Sheath Gas Flow 
11 l/min; Capillary 
Voltage 3000 V; 
deltaEMV 600 
Scopolamin Q: 304,2-->156 (10); 
q 304,2-->138 (18); Atropin Q 
290,3-->124,1 (20); q 290,3--
>93,1 (30) 
Supplied 
along with 
the PT 
samples 
MMC 
14 ZIC-Hilic (SeQuant Merck) 
150mm*2,1mm*5µm; start  10% (5% 
ACN+95% ammoniumacetate) 90% 
(95%ACN+5%ammoniumacetate) 
gradient mode; 30°C; 0,3 ml/min; 10 
µl 
LC-MS/MS 
(API4000QTrap) 
ESIpositive, DP 76V 
(atropine), 51V 
(scopolamine), CE 
35eV(atropine) 31eV 
(scopolamine), CXP 6V 
atropine Q 290,1-124,1 C 290,1-
93,1 
Supplied 
along with 
the PT 
samples 
 
15 UPLC Acquity Waters Acquity BEH C18 
1.8 µm (150 x 2.1 mm).. The gradient 
is 100 % A for 2 min and then goes to 
Waters Acquity UPLC, the 
MS is a Waters Xevo TQ-
S triple quadrupole. The 
Primary transition Atropine 
290>124, CE=20eV, scopolamine 
304>138, CE=20eV, secondary 
Our own SPS 
  
50 
40 % A 60 % B at 12 min.  We then 
step it up to 99 % B for a 3 min flush 
and re-equilibrate for 5 min.. A is 10 
mM ammonium carbonate in water at 
pH 10 (adjusted with ammonia) and B 
is acetonitrile. 
capillary voltage was 2 
kV and the desolvation 
temperature was 500 oC. 
transitions were 290>93 CE = 25 
eV for atropine and 304>103 CE 
= 30 eV for scopolamine. 
18 F5 column, 10cm x 2.1 mm, 2.7 um 
particle size, mob. phase water+0.1% 
FA and MeOH+0.1% FA gradient, 
temp. 40oC, flow rate 0.3 mL/min, inj. 
vol. 10 uL 
LC-MS/MS, Thermo 
Finnigan TSQ Quantum, 
ESI+, Spray Voltage 
3400V, Cap. Temp. 
325oC 
Atropine: Q: 124.2 (22V), C: 93.1 
(31V) 
Supplied 
along with 
the PT 
samples 
SPS 
19 Column Oven Agilent 1290 G1316C 
Agilent 1260 G1312B 0 
AutoSampler CTC 
see 11 see 11   
21 Waters UPLC BEH C18 (1.0 mm id * 
100 mm), 40 ºC, flow 0.150 mL/min, 
Mobile phase A: 6.65 mM ammonium 
hydroxide pH 10.0 ; Mobile phase B: 
acetonitrile . 2 microL inyected 
WATERS TQD (MS/MS), 
ESI positive, cone 
voltage 30 V, capillary 3 
V, desolvation 
temperature 400 ºC 
Atropine 289.9->124.1 (CID 25 
V) 
Scopolamine 303.9 ->138.1 (CID 
40 V) 
Our own MMC 
23 RP18plus, Macherey-Nagel, 
Nucleoshell, 100 mm x 2 mm. 2.7 µm. 
30°C, 0,3 mL/min, 5  µL 
Agilent 6490, ESI +, Atropin 290.2/124.1 (CE28 V), 
Atropin 290.2/77 (CE 60 V), 
Atropin 290.2/93 (CE 37 V); 
Scopolamin 304.2/103 (CE 49 V), 
Scopolamin 304.2/138 (CE 21 V), 
Scopolamin 304.2/156 ( 
Our own SPS 
24 1. Aqua C18, 3 µm, 50 x 2 mm;   2. 
Gemini C18, 3 µm, 100 x 3 mm in 
series connection 
mobile phase A: 10 mM 
Ammoniumbicarbonate in water 
mobile phase B: Acetonitrile 
temperature: 40 °C 
flow rate: 200 µl/min 
inject. vol.: 5 µl 
LC-MS instrument: API 
5500 QTRAP 
ESI positiv 
Ions spray voltage: 5500 
V 
Temperature: 500 °C 
Atropine: Q1: 124  CE: 33 
               Q3: 93    CE: 39 
Scopolamine: Q1:  156   CE: 23 
                       Q3:  103  CE: 55 
                       Q3:  103 
Atropine-d3:    Q1:  127  CE: 33 
                       Q3:    77  CE: 85 
Our own SPS 
25 Pentafluorophenyl column, Ascentis 
Express F5. 100mmx2.1mm 2.7µm; 
water/acetonitrile with 0.1% formic 
acid; 40 °C; 0.3 ml/min; 10 µL 
injection volume 
LC-MS, ABSciex 5500 
QTrap, ESI positiv, IS 
2500 V, TEM 200 °C 
atropine: Q 290-->124 CE 33 V, 
C 290-->93 CE 39 V. 
scopolamine: Q 304-->156 CE 25 
V, C 304-->138 CE 29 V. 
scopolamine: Q 304 --> 156 CE 
25 V, C 304 --> 138 CE 29 V 
Supplied 
along with 
the PT 
samples 
SPS 
27 Column: XBridge Amide, Waters, 
150x2,1 mm, particle size 3,5 um, 
temperature 30 C, flow rate 0,2 
mL/min, injection volume 20 uL. Mobile 
phase: water and acetonitrile. 
LC-MS/MS, Thermo 
Finnigan type TSQ 
Quantum ULTRA EMR, 
ESI (+); Spray voltage 
4000 V; Dessolvation 
temperature: 200 C, 
Capillary temp. 325 C. 
290.030>93.100 (31V); 
290.030>124.200 (22V); 
295.120>93.100 (31V); 
295.120>124.170 (24V);  
304.100>138.140 (22V); 
304.100>156.180 (22V); 
304.100>182.200 (20V); 
308.100>142.160 (22V);  
308.100>160.200 (22V); 
Supplied 
along with 
the PT 
samples 
SPS 
28 Ascentis Express F5 10cm x 2,1 mm 
2,7 
LC-MS/MS Quattro 
Ultima Platinum Waters 
Atropine Q 124.3 C 93.1 
Scopolamine Q 138.0 C 155.9 
Supplied 
along with 
the PT 
samples 
SPS 
30 Supelco Ascentis Express F5; 10cm * 
2.1mm, 2,7µm; Water 0,01% Formic 
Acid, Acetonitrile + 0,01% Formic Acid; 
0.300 ml/min; 10µl Inj 
LC-MSMS ABSciex 
400QTrap; Esi pos; DP 
71, CD 27 
Scopolamin: 304,007 - 155,9 
304,007 - 138,0 
Atropin: 290,032 - 124,0 
290,032 - 93,0 
Our own MMC 
31 Waters BEH C18: 1.7 um; 2.1x50 mm; 
injection 5 ul; 0.3 ml/min. gradient 
elution Water/Methanol with 0.1% 
formic acid 
UPLC-MS/MS Waters 
Acquity TQD 
atropine: 290.1-93.1/290.1-
124.1. atropine IS: 295.1-
93.1/295.1-124.1. scopolamine: 
304-138.1/304-156. scopolaine 
IS: 308-142.1/308-160 
  
33 Waters Aquity BEH C18 1,7 µm, 2,1 x 
50 mm 
LC-MSMS: Waters 
Acquity Xevo TQD, ESI+ 
Scopolamin: 304 -> 138 (Q); 304 
-> 103 (C) 
Our own MMC 
34 look PT TA in cereal-based products look PT TA in cereal-
based products 
look PT TA in cereal-based 
products 
Our own MMC 
35 Kinetex C18 2.6µ 100A; lenght: 
100mm; inner diameter: 2.1mm; 
particle size: 2.6µm; Eluent A: Water 
with 0,1% Formic acid; Eluent B: MeOH 
with 0,1% Formic acid; Gradient from 
10% B at 0 Min. to 90% B at 10 Min.; 
Temperature 35°C; 
Sciex QTrap 5500; ESI 
pos.; 5500 Volts; 650°C 
Atropin:  290.078 --> 124.0; CE 
33 ; 290.078 --> 93.0; CE 39;. 
Scopolamin : 304.062 --> 138.1; 
CE 27; 304.062 --> 156.1; CE 
23; 
Supplied 
along with 
the PT 
samples 
SPS 
36 As supplied ESI: Positive, KV:3.75, 
Cone:35, Source 
Scopolamine:304.3 >138(Q) CID 
22 304.3> 156.1(C) CID 55  /  
Supplied 
along with 
MMC 
  
51 
Temp:120, Desolvation 
Temp:280 
Atropine 290.3> 124.2(Q) CID 26  
290.3>93.2 CID 21 
the PT 
samples 
37 C18 column, 2.1 x 150 mm, 1.8 
micron; mobile phases: H2O (A) and 
MeOH (B) both containing formic acid 
and ammonium formiate, injection 1µl, 
flow rate 0.5 ml/min 
LC-MS/MS, ESI mode 
(pos.) 
Atropin: Q 290.2 > 124 (CE = 
21); 290.2 > 93 (CE = 29). 
Scopolamin: Q 304.2 > 156 (CE 
= 9); C 304.2 > 138 (CE = 21) 
MMC  
38 Agilent Zorbax Eclipse Plus C18 RRHD 
2,1 x 100mm  1,8µm, 
Acetonitril/Methanol/Water 1:1+0,1 
%FA / Water+0,1% FA   10:90, 40°C,  
Flow: 0,4µl, Inj: 5µl 
Agilent 6460, LC-MS/MS, 
ESI+, 3000V, 400°C 
Scopolamin: Quant: 304.2 > 
156.1, Quali: 304.2 > 138.1, 
304.2 >103 
Atropin:  Quant: 290.2 > 124, 
Quali: 290.2 > 93 
Supplied 
along with 
the PT 
samples 
MMC 
40 XBridge C18, 5µm, 3.0 x 150 mm, 
Waters; mobile phase: 
water/acetonitrile, 6 mM NH4OH; 40 
°C 
LC-MSMS; Waters TQ; 
ES+; 2 kV; 400 °C 
Atropine: 290.16 > 124.24 (25 
eV); 290.16 > 93.17 (25 eV); 
Scopolamine: 304.21 > 138.25; 
304.21 > 156.25 
Supplied 
along with 
the PT 
samples 
SPS 
41 Column = Acquity UPLC HSS T3, (1.8 
µm, 2.1x 100 mm) 
Eluens A = 0.02% formic acid in H2O 
Eluens B= 0.02% fomic acid in 
acetonitril 
Temp. 40°C, flow rate = 0,3 ml/min, 
injection volume = 2.0 µl 
LC=MS-MS, ESI+, 
capillary voltage = 
1.05V,  
dessolvation 
temperature=600°C 
Atropine: 290.1 ->124.1 (23 eV) 
/ 290.1->   93.1 (28 eV) 
Scopolamine: 304.1-> 138.0 (20 
eV) / 304.1-> 156.0 (16 eV) 
CID-Energy 
Our own SPS 
42 50 x 2,1 mm Kinetex C18, 2,6 µm, 
gradient, 0.2% formic acid in water 
and methanol, 25°C, 0.3 mL/min, 10 
µL 
LC-MS/MS, API 5500 
(Sciex), ESI positive 
atropine Q 290.0 -> 124.0, CE 
33; C 290.0 -> 93.0, CE 45   / 
scopolamine Q 304.1 -> 138.0, 
CE 31;  304.1 -> 103.1; CE  50 
Our own MMC 
44 n.s. LC-MS/MS (Sciex API 
5500) 
n.s. Our own SPS 
45 Macherey-Nagel, Nucleoshell RP 
18plus, 150 x 2 mm, particle diameter: 
2,7 µm; eluent a: 315 mg ammonium 
formate + 1 ml formic acid + 1 l water; 
eluent b: 315 ammonium formate + 1 
ml formic acid + 1 l methanol 
LC-MS/MS; 5500 Triple 
Quad (SCIEX), ESI 
positive, 4500 V, 550 °C 
Atropine: 290-->124 (Q), CID 
41V; 290-->93 (C), CID 43V; 
scopolamine: 304-->138 (Q), CID 
31V; 304-->156 (C), CID 23V 
Supplied 
along with 
the PT 
samples 
SPS 
46 Waters UPLC BEH C18 150x2.1 mm, 
1.7 um. mobile phaes A: 10 mM 
ammonium carbonate pH 10.0, mobile 
phase B: acetonitrile. 400 ul/min, 50°C 
Waters Xevo TQ-S LC-
MS/MS. Pos ESI, cap V: 
3.0 kV, cone: 30 V., 
desolvation gas: 600°C, 
cone : 150°C, collission 
gas: argon, 4.2x10-3 
mbar 
Atropine: Q = 290.2 > 124.0, CE: 
20 eV; C = 290.2 > 93.0, CE: 25 
eV. 
Scopolamine: Q = 304.2 > 138.0, 
CE: 20 eV; C = 304.2 > 103.0, 
35 eV. 
Our own MMC 
47 Waters Acquity BEH 150 + 2.1 mm, 
1.7 µm 
LC-MS² AbSciex 5500 in 
ESI+ mode 
Q(Atropin) = 290,2 / 124 CE = 
33eV  C(Atropin) = 290.2 / 93.0  
CE = 49 eV  Q(Scopolamin) = 
304.2 / 138.1  CE = 29 eV 
C(Scopolamin) = 304.2 / 156.1  
CE =  23 eV 
Supplied 
along with 
the PT 
samples 
SPS 
50 Water Xselect HSS T3, 2.5 µm 2.1 x 
100 mm, Methanol, Water + 1% 
Formic Acid, Flow Rate 350 µm7min, 5 
ml 
LC-MS/MS, SCIEX QTrap 
5500, Esi pos, 400 °C, 
5500 V 
Scopalamin: 304>138.2 DP 66V; 
CE 27 V; 304>156, DP 66 V, CE 
23 .Aropin; 290>124.1 DP 96V; 
CE 33 V; 290>92.9 DP 96 V; CE 
39 V 
Supplied 
along with 
the PT 
samples 
SPS 
52 Supelco ascentis express F5 
10cmx2.1mm; 2.7um 
Waters UPLC-Quattro 
premier. parameters as 
reported in the EURL 
method 
Same as reported in the EURL 
methods 
Supplied 
along with 
the PT 
samples 
SPS 
53 Thermo Hypersil Gold (150 x 2,1 mm, 
3 micrometer) 
eluent A water, eluent B methanol 
temperature 40°C 
flow rate 300 mL/min 
injection volume 10 
SCIEX API 400, SCIEX 
Qtrap5500 
ESI + 
dessolvation temperature 
500°C 
IS 5500 
Atropine 290.259/124.200     CE 
31     CXP 8 /  290.259/93.000       
CE 39     CXP 14 /290.259/91.000       
CE 59     CXP 10 / DP 106   EP 10 
Scopolamine 304.232/138.100          
CE61      CXP10 / 
304.232/156.100          CE23      
CXP12  / 304.232/103.000    
CE55   CXP10  DP61    EP10 
Our own SPS 
 
* Approach for calibration: MMC – matrix-matched calibration / SPS – standards in pure solvent 
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Lab Q.16 
Strategy used for 
LOD/LOQs estimation 
Q.17 
Performance 
parameters SCOP 
Q.18 
Performance 
parameters ATROP 
Q.19 
Recovery calculation 
Q.28 
Results 
reported 
2 
low level spiking R2=0,99985549 R2=0,99996418 spiking matrix NOT CORRECTED 
for recoveries 
4 
S/N  3.1 qualifier for 
LOD; 10 : 1 qualifier for 
LOQ 
R^2 = 0,99885797 R^2 = 0,99918363 isotope labled internal 
standard 
NOT CORRECTED 
for recoveries 
5 
cfr. Methode Cereal 
Products 
cfr. Method Cereal 
Products 
cfr. Methode Cereal 
Products 
cfr. Methode Cereal 
Products 
NOT CORRECTED 
for recoveries 
7 
the lowest validated level 
was chosen as an LOQ 
(2.5 ppb) 
R2=0.998 
Scopolamine (conc: 
RSD% day1 to 3) : 2.5 
ppb: 4.31/ 50 pbb: 
5.66/150 ppb: 11.65 
R2 =0.988 Atropine 
(conc: RSD% day1 to 
3) : 2.5ppb: 19.90/ 50 
pbb: 8.19/150 ppb: 
11.50 
based on the in 
validation spiked 
cereal samples- a total 
mean recovery per 
component was 
determined which 
included results of  3 
days and 3 
concentrations 
NOT CORRECTED 
for recoveries 
13 
 R2=0.997 R2=0.998 spiked blank sample, 
whole analytical 
procedure 
NOT CORRECTED 
for recoveries 
14 
LOD S/N 3 RSD % 1-8 % 
standard addition 
curve > 0,98 
RSD % 1-8 % 
standard addition 
curve > 0,98 
spiked matrix NOT CORRECTED 
for recoveries 
15 
LOQ = lowest calibration 
standard 
r2=0.998 r2=0.998 Internal standard 
added before 
extraction to carry out 
inherent recovery 
correction. 
CORRECTED for 
recoveries 
18 
parameters from the 
calibration curve 
R2=0.9981 R2=0.9978 Spiked blank matrix CORRECTED for 
recoveries 
19 
calibration curve RSD <20%, >0,999 RSD <20%, >0,999 0,2-2µg/kg CORRECTED for 
recoveries 
21 
LOD = s/n 3 r=0.998 r=0.998 recovery not 
calculated for these 
matrices 
NOT CORRECTED 
for recoveries 
23 
low level spikes 1.6 %, 0.998 3,18 %, 0.997 spiked matrix NOT CORRECTED 
for recoveries 
24 
S/N ratio (3 and 10) of 
each sample and spiking 
each sample 
r= 0.9995 (linear 
regression) 
r= 0.9996 (linear 
regression) 
spiked matrix NOT CORRECTED 
for recoveries 
25 
S/N 3 and 10 2 %, 0,9999 3 %, 0,9998 spiked matrix CORRECTED for 
recoveries 
27 
   Spiked matrix CORRECTED for 
recoveries 
28 
S/N, blank and low level 
spike 
R2 0,999 R2 0,999 spiked matrix NOT CORRECTED 
for recoveries 
30 
Low Level spike r=0,99657 r=0,98981 Procedural Standard 
Calibration 
CORRECTED for 
recoveries 
31 
estimation from standard 
curve 
  determination of ratio 
of [analyte in solution 
of spiked 
sample]/[theoretical 
concentration 
calculated from area of 
spiked solution diluted 
in mobile phase] 
 
33 
S/N ration (3 and 10) of 
spiked blanks 
r = 0,99836 r = 0,99919 spiked blank matrices NOT CORRECTED 
for recoveries 
34 
S/N ratio 10 %; 0.9973 6 % ; 0.9984 spiked matrix NOT CORRECTED 
for recoveries 
35 
DIN 32645 (Calibration 
Curve with Std.'s in low 
Concentration) 
   NOT CORRECTED 
for recoveries 
36 
LOD Taken as lowest std 
& LOQ lowest std  x 
calculation of method 
factor 
Black tea:0.998765, 
PM:0.998849, 
Fennel:0.99775 
Black tea:0.996609,  
PM:0.997278, 
Fennel:0.999009 
As requested 0.2 mls 
of spiking sol into 2g 
as requested 
CORRECTED for 
recoveries 
37 
low level spikes   we used spiked matrix  
53 
38 
S/N   (3 and 10, Peak-to-
Peak) 
99,99%,  0,999922 99,99%,  0,999889 Matrix calibration NOT CORRECTED 
for recoveries 
40 
S/N ratio 3/6, 
respectively 
24.6; 0.999 16.4; 0.998 Spiked matrix NOT CORRECTED 
for recoveries 
41 
Blank low level spikes + 
s/n ratio 
RSD = 20%; 
correlation coeficient 
=0.9999 
RSD= 25%;,  
correlation coefficient 
=0.9999 
spiked matrix NOT CORRECTED 
for recoveries 
42 
low level spikes 0.998 0.999 spiked matrix NOT CORRECTED 
for recoveries 
44 
S/N ratio n.s. n.s. n.s. NOT CORRECTED 
for recoveries 
45 
S/N ratio (LOQ: 10; LOD: 
3), low level spikes 
0.9998 0.9999 - NOT CORRECTED 
for recoveries 
46 
LOD: S/N =3 for 
secondary transition 
(rounded off) 
LOQ: S/N = 6 for 
secondary transition 
(rounded off) 
calibration: 0.998-
1.000 
calibration: 0.999-
1.000 
Spiked to blank matrix 
(3 PT materials 
supplied) 
CORRECTED for 
recoveries 
47 
S/N ratio 3 and 10 for 
LOD, LOQ respectively in 
low level spiked samples 
r = 0.99898  RSD 
= 5.14% 
r = 0.99989  RSD 
= 4.03% 
Matrix spiked with 
internal standard 
(SIDA) 
NOT CORRECTED 
for recoveries 
50 
LOD: S/N 3: LOQ: S/N: 5 r = 0.999 r = 0.999 NOT CORRECTED 
for recoveries 
52 
LOD S/N=3; LOQ S/N=6 17 13 spiked matrix NOT CORRECTED 
for recoveries 
53 
S/N ratio - - spiked matrix NOT CORRECTED 
for recoveries 
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JRC Mission 
As the Commission’s  
in-house science service,  
the Joint Research Centre’s 
mission is to provide EU  
policies with independent,  
evidence-based scientific  
and technical support  
throughout the whole  
policy cycle. 
Working in close  
cooperation with policy  
Directorates-General,  
the JRC addresses key  
societal challenges while  
stimulating innovation  
through developing  
new methods, tools  
and standards, and sharing 
its know-how with  
the Member States,  
the scientific community  
and international partners. 
Serving society  
Stimulating innovation 
Supporting legislation 
